<?xml version="1.0" encoding="UTF-8"?><urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"><url><loc>https://market-access-solutions.ru/</loc></url><url><loc>https://market-access-solutions.ru/105-retrospektivnoe-issledovanie.html</loc></url><url><loc>https://market-access-solutions.ru/2264-fas-predstavila-shemy-lekobespecheniya-pacientov-s-serdechno-sosudistymi-zabolevaniyami.html</loc></url><url><loc>https://market-access-solutions.ru/about.html</loc></url><url><loc>https://market-access-solutions.ru/about_eng.html</loc></url><url><loc>https://market-access-solutions.ru/activity</loc></url><url><loc>https://market-access-solutions.ru/activity/</loc></url><url><loc>https://market-access-solutions.ru/activity/1150-ii-mezhdunarodnaya-konferenciya-dokazatelnaya-medicina-ot-teorii-k-praktike-erevan-24-26-sentyabrya-2015-g.html</loc></url><url><loc>https://market-access-solutions.ru/activity/1200-mezhdunarodnaya-vystavka-vitaktiva-moskva-17-19-noyabrya-2015-g.html</loc></url><url><loc>https://market-access-solutions.ru/activity/1555-41-ya-mezhregionalnaya-specializirovannaya-vystavka-zdravoohranenie.html</loc></url><url><loc>https://market-access-solutions.ru/activity/1644-forum-zdravoohranenie-kryma-2016-proydet-v-simferopole-11-oktyabrya.html</loc></url><url><loc>https://market-access-solutions.ru/activity/1703-v-moskve-9-noyabrya-2016-goda-sostoitsya-vii-vserossiyskiy-kongress-pacientov.html</loc></url><url><loc>https://market-access-solutions.ru/activity/1754-yubileynaya-premiya-russian-pharma-awards-2016-polmilliona-vrachey-vyberut-luchshie-farmacevticheskie-preparaty-2016-goda.html</loc></url><url><loc>https://market-access-solutions.ru/activity/1772-press-konferenciya-obespechenie-effektivnogo-kontrolya-ispolzovaniya-gosudarstvennyh-sredstv-v-nauke-i-zdravoohranenii-vazhneyshaya-osnova-ekonomicheskoy-bezopasnosti-rf-.html</loc></url><url><loc>https://market-access-solutions.ru/activity/1842-forum-zdorove-rossii-sochi-2017-specializirovannaya-vystavka-medicina-segodnya-i-zavtra-dolgoletie-krasoty-i-zdorovya-zdorovyy-obraz-zhizni-wellness.html</loc></url><url><loc>https://market-access-solutions.ru/activity/1904-vserossiyskaya-konferenciya-realnyy-put-ot-nauchnyh-razrabotok-do-lekarstvennyh-sredstv.html</loc></url><url><loc>https://market-access-solutions.ru/activity/1967-4-ya-mezhdunarodnaya-konferenciya-klinicheskie-issledovaniya-v-rossii-i-eaes.html</loc></url><url><loc>https://market-access-solutions.ru/activity/1983-xii-nacionalnyy-kongress-farmakoekonomika-2018.html</loc></url><url><loc>https://market-access-solutions.ru/activity/1992-vi-vserossiyskiy-kongress-farmacevticheskaya-deyatelnost-v-rossii-i-eaes-normativno-pravovoe-regulirovanie-2018-leto.html</loc></url><url><loc>https://market-access-solutions.ru/activity/210-kto-razdelit-pirog-zdravoohraneniya-novoe-partnerstvo-i-novye-dvizhuschie-sily-farmacevticheskogo-rynka.html</loc></url><url><loc>https://market-access-solutions.ru/activity/2219-mezhdunarodnaya-nauchno-prakticheskaya-konferenciya-razvitie-ocenki-tehnologiy-zdravoohraneniya-v-stranah-sng.html</loc></url><url><loc>https://market-access-solutions.ru/activity/493-xv-yubileynaya-rossiyskaya-nauchno-prakticheskaya-konferenciya-davidenkovskie-chteniya-innovacii-v-nevrologii.html</loc></url><url><loc>https://market-access-solutions.ru/activity/517-35-y-kongress-evropeyskogo-obschestva-po-klinicheskomu-pitaniyu-i-metabolizmu-sobral-rekordnoe-chislo-specialistov.html</loc></url><url><loc>https://market-access-solutions.ru/activity/585-zdravoohranenie-yuga-rossii-2014.html</loc></url><url><loc>https://market-access-solutions.ru/activity/663-mezhdunarodnyy-kongress-po-klinicheskoy-farmakologii-i-farmakoterapii.html</loc></url><url><loc>https://market-access-solutions.ru/activity/735-nauchno-prakticheskaya-konferenciya-s-mezhdunarodnym-uchastiem-trudnye-voprosy-akusherstva-i-ginekologii-14-15-oktyabrya-2014-g-ekaterinburg.html</loc></url><url><loc>https://market-access-solutions.ru/activity/768-otkryt-priem-zayavok-na-soiskanie-tretey-socialnoy-premii-dasigna-2014-goda-po-farmakoekonomike.html</loc></url><url><loc>https://market-access-solutions.ru/analytics/</loc></url><url><loc>https://market-access-solutions.ru/analytics/consumption_medicines</loc></url><url><loc>https://market-access-solutions.ru/analytics/consumption_medicines/</loc></url><url><loc>https://market-access-solutions.ru/analytics/consumption_medicines/131-analiz-potrebleniya-statinov-v-rossii-v-2010-2011-godu.html</loc></url><url><loc>https://market-access-solutions.ru/analytics/epidemiology</loc></url><url><loc>https://market-access-solutions.ru/analytics/epidemiology/</loc></url><url><loc>https://market-access-solutions.ru/analytics/epidemiology/762-doklad-o-sostoyanii-zdorovya-naseleniya-i-organizacii-zdravoohraneniya-po-itogam-deyatelnosti-organov-ispolnitelnoy-vlasti-subektov-rf-za-2013-god.html</loc></url><url><loc>https://market-access-solutions.ru/analytics/foresight</loc></url><url><loc>https://market-access-solutions.ru/analytics/hta</loc></url><url><loc>https://market-access-solutions.ru/analytics/hta/</loc></url><url><loc>https://market-access-solutions.ru/analytics/hta/396-vyshli-v-svet-rekomendacii-ocenka-medicinskih-tehnologiy-pod-obschey-redakciey-chlen-korr-ramn-belousova-yub-m-2013-g.html</loc></url><url><loc>https://market-access-solutions.ru/analytics/hta/604-raschet-zatrat-pri-ekonomicheskoy-ocenke-medicinskih-tehnologiy.html</loc></url><url><loc>https://market-access-solutions.ru/analytics/need_medicines</loc></url><url><loc>https://market-access-solutions.ru/analytics/need_medicines/</loc></url><url><loc>https://market-access-solutions.ru/analytics/need_medicines/552-osnovy-tehnologii-dostupa-na-rynok.html</loc></url><url><loc>https://market-access-solutions.ru/analytics/slides.xml</loc></url><url><loc>https://market-access-solutions.ru/contacts.html</loc></url><url><loc>https://market-access-solutions.ru/contacts_eng.html</loc></url><url><loc>https://market-access-solutions.ru/education</loc></url><url><loc>https://market-access-solutions.ru/engine/download.php</loc></url><url><loc>https://market-access-solutions.ru/favicon.ico</loc></url><url><loc>https://market-access-solutions.ru/healtheconomics/</loc></url><url><loc>https://market-access-solutions.ru/healtheconomics/h_t_a</loc></url><url><loc>https://market-access-solutions.ru/healtheconomics/h_t_a/</loc></url><url><loc>https://market-access-solutions.ru/healtheconomics/h_t_a/167-ocenka-medicinskih-tehnologiy-i-formirovanie-politiki-zdravoohraneniya-v-stranah-evropy.html</loc></url><url><loc>https://market-access-solutions.ru/healtheconomics/h_t_a/168-mezhdunarodnyy-opyt-ocenki-tehnologiy-v-zdravoohranenii.html</loc></url><url><loc>https://market-access-solutions.ru/healtheconomics/h_t_a/169-ocenka-medicinskih-tehnologiy-opredelenie.html</loc></url><url><loc>https://market-access-solutions.ru/healtheconomics/h_t_a/178-predstavlenie-i-interpretaciya-rezultatov-omt.html</loc></url><url><loc>https://market-access-solutions.ru/healtheconomics/h_t_a/179-modelirovanie-v-omt.html</loc></url><url><loc>https://market-access-solutions.ru/healtheconomics/h_t_a/180-ocenka-zatrat-v-omt.html</loc></url><url><loc>https://market-access-solutions.ru/healtheconomics/h_t_a/181-ocenka-ishodov-v-omt.html</loc></url><url><loc>https://market-access-solutions.ru/healtheconomics/h_t_a/182-dannye-ispolzuemye-pri-provedenii-ekonomicheskoy-ocenki-medicinskih-tehnologiy-omt.html</loc></url><url><loc>https://market-access-solutions.ru/healtheconomics/h_t_a/183-diskontirovanie-pri-omt.html</loc></url><url><loc>https://market-access-solutions.ru/healtheconomics/h_t_a/184-vremennoy-gorizont-pri-omt.html</loc></url><url><loc>https://market-access-solutions.ru/healtheconomics/h_t_a/185-sravnitelnyy-analiz-metodov-medicinskogo-vmeshatelstva-pri-omt.html</loc></url><url><loc>https://market-access-solutions.ru/healtheconomics/h_t_a/186-issleduemaya-populyaciya-pri-omt.html</loc></url><url><loc>https://market-access-solutions.ru/healtheconomics/h_t_a/187-perspektivy-primeneniya-omt.html</loc></url><url><loc>https://market-access-solutions.ru/healtheconomics/h_t_a/188-vidy-ekonomicheskoy-ocenki-medicinskih-tehnologiy-omt.html</loc></url><url><loc>https://market-access-solutions.ru/healtheconomics/h_t_a/767-opublikovany-standarty-ocenki-medicinskih-tehnologiy-gost-r-56044-2014.html</loc></url><url><loc>https://market-access-solutions.ru/healtheconomics/h_t_a/page/2/</loc></url><url><loc>https://market-access-solutions.ru/healtheconomics/pharmacoeconomics</loc></url><url><loc>https://market-access-solutions.ru/healtheconomics/pharmacoeconomics/</loc></url><url><loc>https://market-access-solutions.ru/healtheconomics/pharmacoeconomics/191-farmakoekonomika-eto.html</loc></url><url><loc>https://market-access-solutions.ru/healtheconomics/pharmacoeconomics/192-cost-of-illness.html</loc></url><url><loc>https://market-access-solutions.ru/healtheconomics/pharmacoeconomics/193-cost-minimization-analysis.html</loc></url><url><loc>https://market-access-solutions.ru/healtheconomics/pharmacoeconomics/194-cost-effectiveness-analysis.html</loc></url><url><loc>https://market-access-solutions.ru/healtheconomics/pharmacoeconomics/195-cost-utility-analysis.html</loc></url><url><loc>https://market-access-solutions.ru/healtheconomics/pharmacoeconomics/197-cost-benefit-analysis.html</loc></url><url><loc>https://market-access-solutions.ru/healtheconomics/pharmacoepidemiology</loc></url><url><loc>https://market-access-solutions.ru/healtheconomics/pricing</loc></url><url><loc>https://market-access-solutions.ru/healtheconomics/qol</loc></url><url><loc>https://market-access-solutions.ru/healtheconomics/reimbursement</loc></url><url><loc>https://market-access-solutions.ru/healtheconomics/systematic_reviews</loc></url><url><loc>https://market-access-solutions.ru/index.php</loc></url><url><loc>https://market-access-solutions.ru/index.php?action_skin_change=yes&amp;skin_name=english</loc></url><url><loc>https://market-access-solutions.ru/index.php?do=lostpassword</loc></url><url><loc>https://market-access-solutions.ru/index.php?do=register</loc></url><url><loc>https://market-access-solutions.ru/index.php?newsid=1165</loc></url><url><loc>https://market-access-solutions.ru/index.php?newsid=509</loc></url><url><loc>https://market-access-solutions.ru/index.php?newsid=687</loc></url><url><loc>https://market-access-solutions.ru/index.php?newsid=691</loc></url><url><loc>https://market-access-solutions.ru/index.php?newsid=699</loc></url><url><loc>https://market-access-solutions.ru/index.php?newsid=700</loc></url><url><loc>https://market-access-solutions.ru/index.php?newsid=705</loc></url><url><loc>https://market-access-solutions.ru/index.php?newsid=707</loc></url><url><loc>https://market-access-solutions.ru/index.php?newsid=708</loc></url><url><loc>https://market-access-solutions.ru/index.php?newsid=762</loc></url><url><loc>https://market-access-solutions.ru/index.php?newsid=938</loc></url><url><loc>https://market-access-solutions.ru/index.php?newsid=958</loc></url><url><loc>https://market-access-solutions.ru/index.php?newsid=959</loc></url><url><loc>https://market-access-solutions.ru/index.php?newsid=960</loc></url><url><loc>https://market-access-solutions.ru/index.php?newsid=961</loc></url><url><loc>https://market-access-solutions.ru/index.php?newsid=962</loc></url><url><loc>https://market-access-solutions.ru/index.php?newsid=963</loc></url><url><loc>https://market-access-solutions.ru/index.php?newsid=964</loc></url><url><loc>https://market-access-solutions.ru/index.php?newsid=965</loc></url><url><loc>https://market-access-solutions.ru/index.php?newsid=966</loc></url><url><loc>https://market-access-solutions.ru/index.php?newsid=967</loc></url><url><loc>https://market-access-solutions.ru/index.php?newsid=985</loc></url><url><loc>https://market-access-solutions.ru/index.php?newsid=986</loc></url><url><loc>https://market-access-solutions.ru/index.php?newsid=987</loc></url><url><loc>https://market-access-solutions.ru/index.php?newsid=988</loc></url><url><loc>https://market-access-solutions.ru/index.php?newsid=989</loc></url><url><loc>https://market-access-solutions.ru/index.php?newsid=990</loc></url><url><loc>https://market-access-solutions.ru/index.php?newsid=991</loc></url><url><loc>https://market-access-solutions.ru/index.php?newsid=992</loc></url><url><loc>https://market-access-solutions.ru/index.php?newsid=993</loc></url><url><loc>https://market-access-solutions.ru/index.php?newsid=994</loc></url><url><loc>https://market-access-solutions.ru/legislation</loc></url><url><loc>https://market-access-solutions.ru/legislation/</loc></url><url><loc>https://market-access-solutions.ru/legislation/1382-predlagaetsya-usovershenstvovat-zakonodatelstvo-dlya-uproscheniya-dostupa-na-rynok-rossiyskih-preparatov.html</loc></url><url><loc>https://market-access-solutions.ru/legislation/139-pravovoe-regulirovanie-poryadka-predostavleniya-platnyh-medicinskih-uslug-v-byudzhetnyh-lechebnyh-uchrezhdeniyah.html</loc></url><url><loc>https://market-access-solutions.ru/legislation/1415-minzdrav-podgotovil-izmeneniya-v-zakonodatelstvo-v-svyazi-s-prinyatiem-fz-o-biomedicinskih-kletochnyh-produktah.html</loc></url><url><loc>https://market-access-solutions.ru/legislation/1443-minzdrav-razrabatyvaet-proekt-federalnogo-zakona-o-poryadke-opredeleniya-vzaimozamenyaemosti-zaregistrirovannyh-lekarstv.html</loc></url><url><loc>https://market-access-solutions.ru/legislation/1462-minzdravom-razrabotan-poryadok-opredeleniya-vzaimozamenyaemosti-zaregistrirovannyh-lp.html</loc></url><url><loc>https://market-access-solutions.ru/legislation/1469-preparaty-dlya-lecheniya-orfannyh-zabolevaniy-budut-zakupatsya-za-schet-sredstv-federalnogo-byudzheta.html</loc></url><url><loc>https://market-access-solutions.ru/legislation/1648-minzdrav-vneset-izmeneniya-v-poryadok-opredeleniya-vzaimozamenyaemosti-preparatov.html</loc></url><url><loc>https://market-access-solutions.ru/legislation/1976-v-gosdumu-napravlen-zakonoproekt-o-poryadke-vvoda-v-grazhdanskiy-oborot-leksredstv.html</loc></url><url><loc>https://market-access-solutions.ru/legislation/2093-v-sovete-federacii-podgotovlen-zakonoproekt-o-zakupkah-orfannyh-preparatov.html</loc></url><url><loc>https://market-access-solutions.ru/legislation/245-vneseny-izmeneniya-v-zakon-ob-obraschenii-lekarstvennyh-sredstv.html</loc></url><url><loc>https://market-access-solutions.ru/legislation/246-federalnyy-zakon-ot-12-aprelya-2010-g-61-fz-ob-obraschenii-lekarstvennyh-sredstv.html</loc></url><url><loc>https://market-access-solutions.ru/legislation/252-o-programme-gosudarstvennyh-garantiy-besplatnogo-okazaniya-grazhdanam-medicinskoy-pomoschi-na-2013-god-i-na-planovyy-period-2014-i-2015-godov.html</loc></url><url><loc>https://market-access-solutions.ru/legislation/253-ob-utverzhdenii-pravil-gosudarstvennoy-registracii-medicinskih-izdeliy.html</loc></url><url><loc>https://market-access-solutions.ru/legislation/256-ob-utverzhdenii-poryadka-opredeleniya-cen-tarifov-na-medicinskie-uslugi-predostavlyaemye-medicinskimi-organizaciyami-yavlyayuschimisya-byudzhetnymi-i-kazennymi-gosudarstvennymi-uchrezhdeniyami.html</loc></url><url><loc>https://market-access-solutions.ru/legislation/288-personalnyy-sostav-glavnyh-vneshtatnyh-specialistov-ministerstva-zdravoohraneniya-rossiyskoy-federacii-ot-25-oktyabrya-2012-g.html</loc></url><url><loc>https://market-access-solutions.ru/legislation/311-pravila-organizacii-proizvodstva-i-kontrolya-kachestva-lekarstvennyh-sredstv-gmp.html</loc></url><url><loc>https://market-access-solutions.ru/legislation/342-fz-otmenyaet-gosudarstvennuyu-monopoliyu-na-otdelnye-vidy-oborota-psihotropnyh-veschestv.html</loc></url><url><loc>https://market-access-solutions.ru/legislation/393-sozdan-sovet-po-etike-v-sfere-obrascheniya-medizdeliy.html</loc></url><url><loc>https://market-access-solutions.ru/legislation/417-ustanovlenie-dopolnitelnyh-trebovaniy-pri-razmeschenii-zakazov-na-postavki-lekarstv.html</loc></url><url><loc>https://market-access-solutions.ru/legislation/419-obzor-osnovnyh-polozheniy-proekta-fz-ob-obraschenii-medicinskih-izdeliy.html</loc></url><url><loc>https://market-access-solutions.ru/legislation/427-utverzhden-reglament-vvoza-v-rf-lekarstv-dlya-provedeniya-klinicheskih-ispytaniy.html</loc></url><url><loc>https://market-access-solutions.ru/legislation/434-gosduma-prinyala-vo-vtorom-chtenii-zakonoproekt-o-kontraktnoy-sisteme-v-sfere-goszakupok.html</loc></url><url><loc>https://market-access-solutions.ru/legislation/454-pravitelstvo-rasshirilo-perechen-polnomochiy-minzdrava-rf.html</loc></url><url><loc>https://market-access-solutions.ru/legislation/469-utverzhden-poryadok-organizacii-i-provedeniya-ekspertizy-kachestva-i-bezopasnosti-medizdeliy.html</loc></url><url><loc>https://market-access-solutions.ru/legislation/471-fas-opredelila-klyuchevye-problemy-razvitiya-konkurencii-na-rossiyskom-farmrynke.html</loc></url><url><loc>https://market-access-solutions.ru/legislation/527-utverzhdena-novaya-nomenklatura-medicinskih-organizaciy.html</loc></url><url><loc>https://market-access-solutions.ru/legislation/532-ministerstvo-ekonomicheskogo-razvitiya-rf-podgotovilo-zakonoproekt-vnosyaschiy-izmeneniya-v-federalnyy-zakon-ot-12-aprelya-2010-g-61-fz-ob-obraschenii-lekarstvennyh-sredstv.html</loc></url><url><loc>https://market-access-solutions.ru/legislation/page/10/</loc></url><url><loc>https://market-access-solutions.ru/legislation/page/14/</loc></url><url><loc>https://market-access-solutions.ru/legislation/page/2/</loc></url><url><loc>https://market-access-solutions.ru/legislation/page/3/</loc></url><url><loc>https://market-access-solutions.ru/legislation/page/4/</loc></url><url><loc>https://market-access-solutions.ru/legislation/page/5/</loc></url><url><loc>https://market-access-solutions.ru/legislation/page/6/</loc></url><url><loc>https://market-access-solutions.ru/legislation/page/7/</loc></url><url><loc>https://market-access-solutions.ru/legislation/page/8/</loc></url><url><loc>https://market-access-solutions.ru/legislation/page/9/</loc></url><url><loc>https://market-access-solutions.ru/library</loc></url><url><loc>https://market-access-solutions.ru/library/</loc></url><url><loc>https://market-access-solutions.ru/library/1563-pharmsuitepro-avtomatizirovannoe-rabochee-mesto-vracha-klinicheskogo-farmakologa.html</loc></url><url><loc>https://market-access-solutions.ru/library/1778-analiz-farmakoekonomicheskih-i-kliniko-ekonomicheskih-issledovaniy-predstavlennyh-v-baze-nauchnoy-elektronnoy-biblioteki-elibraryru-rinc-za-period-s-2005-po-2015-gg.html</loc></url><url><loc>https://market-access-solutions.ru/library/196-modeliring.html</loc></url><url><loc>https://market-access-solutions.ru/library/207-horoshaya-prezentaciya-vs-plohaya-prezentaciya.html</loc></url><url><loc>https://market-access-solutions.ru/library/208-klassicheskaya-adaptaciya-prezentacii-dlya-zriteley-v-internete-chast-1.html</loc></url><url><loc>https://market-access-solutions.ru/library/209-klassicheskaya-adaptaciya-prezentacii-dlya-zriteley-v-internete-chast-2.html</loc></url><url><loc>https://market-access-solutions.ru/library/218-pokolenie-y-lyubit-kachestvennuyu-reklamu.html</loc></url><url><loc>https://market-access-solutions.ru/library/397-slaydy-kotorye-ukrashayut-mysli-3-prostyh-pravila-oformleniya-prezentaciy.html</loc></url><url><loc>https://market-access-solutions.ru/library/398-obzor-ploschadok-dlya-onlayn-obucheniya-i-sovmestnoy-raboty.html</loc></url><url><loc>https://market-access-solutions.ru/library/452-farmakonadzor-v-rf-i-es-v-svete-novoy-direktivy-evrosoyuza.html</loc></url><url><loc>https://market-access-solutions.ru/library/453-osnovnye-aspekty-gosudarstvennogo-regulirovaniya-spiska-zhnvlp-v-rf.html</loc></url><url><loc>https://market-access-solutions.ru/library/557-mezhdunarodnyy-opyt-primeneniya-metodov-sravnitelnoy-ocenki-effektivnosti-v-zdravoohranenii.html</loc></url><url><loc>https://market-access-solutions.ru/library/600-vyshel-v-svet-zhurnal-kachestvennaya-klinicheskaya-praktika-2-2013-g.html</loc></url><url><loc>https://market-access-solutions.ru/library/639-vyshli-v-svet-novye-nomera-zhurnala-farmakokinetika-i-farmakodinamika-2013-g.html</loc></url><url><loc>https://market-access-solutions.ru/library/645-vyshel-v-svet-zhurnal-kachestvennaya-klinicheskaya-praktika-3-2013-g.html</loc></url><url><loc>https://market-access-solutions.ru/newposts/</loc></url><url><loc>https://market-access-solutions.ru/news</loc></url><url><loc>https://market-access-solutions.ru/news/</loc></url><url><loc>https://market-access-solutions.ru/news/1002-minzdrav-razrabotal-pravila-izgotovleniya-i-otpuska-lekarstv-aptechnymi-organizaciyami.html</loc></url><url><loc>https://market-access-solutions.ru/news/1007-v-rossiyskoy-federacii-sokratilsya-obem-proizvodstva-lekarstvennyh-sredstv.html</loc></url><url><loc>https://market-access-solutions.ru/news/1019-25-27-marta-xii-specializirovannaya-vystavka-uralstomatologiya-medicina-dlya-zdorovya-i-krasoty.html</loc></url><url><loc>https://market-access-solutions.ru/news/1020-ix-nacionalnyy-kongress-s-mezhdunarodnym-uchastiem-razvitie-farmakoekonomiki-i-farmakoepidemiologii-v-rossiyskoy-federacii.html</loc></url><url><loc>https://market-access-solutions.ru/news/1036-s-1-marta-zapreschaetsya-prodazha-lekarstv-iz-perechnya-zhnvlp-na-kotorye-ne-zaregistrirovana-otpusknaya-cena.html</loc></url><url><loc>https://market-access-solutions.ru/news/1045-zatraty-na-bazovuyu-programmu-oms-i-programmu-gosgarantiy-v-2015-godu-sostavyat-410-mlrd-rubley.html</loc></url><url><loc>https://market-access-solutions.ru/news/1050-eksperty-predlagayut-vyplachivat-rossiyanam-kompensacii-za-pobochnye-effekty-lekarstv.html</loc></url><url><loc>https://market-access-solutions.ru/news/1062-v-gosdumu-vneseny-zakonoproekty-ob-uzhestochenii-gosregulirovaniya-cen-na-lekarstva.html</loc></url><url><loc>https://market-access-solutions.ru/news/1063-neobhodimo-skoreyshee-provedenie-indeksacii-predelnyh-otpusknyh-cen-na-lekarstva.html</loc></url><url><loc>https://market-access-solutions.ru/news/1066-minzdrav-razrabotal-poryadok-opredeleniya-vzaimozamenyaemosti-lekarstvennyh-preparatov.html</loc></url><url><loc>https://market-access-solutions.ru/news/1074-rossiyskaya-procedura-predregistracionnyh-klinicheskih-issledovaniy-v-ramkah-tamozhennogo-soyuza-poka-ostaetsya-prezhney.html</loc></url><url><loc>https://market-access-solutions.ru/news/1076-the-experts-discussed-the-problems-associated-with-the-introduction-of-parallel-imports-and-compulsory-licensing.html</loc></url><url><loc>https://market-access-solutions.ru/news/1078-golodec-schitaet-chto-bolshuyu-chast-inostrannyh-lekarstv-mozhno-zamenit-otechestvennymi.html</loc></url><url><loc>https://market-access-solutions.ru/news/1092-vladimir-putin-podpisal-zakon-o-gosregulirovanii-cen-na-lekarstva.html</loc></url><url><loc>https://market-access-solutions.ru/news/1093-vneseny-izmeneniya-v-zakon-ob-osnovah-ohrany-zdorovya-grazhdan.html</loc></url><url><loc>https://market-access-solutions.ru/news/1094-olga-golodec-farmkompanii-gotovy-sderzhivat-rost-cen-na-lekarstva-v-obmen-na-semiletnie-goskontrakty.html</loc></url><url><loc>https://market-access-solutions.ru/news/1098-minpromtorg-odobril-sderzhivanie-cen-na-lekarstva-v-obmen-na-goskontrakty.html</loc></url><url><loc>https://market-access-solutions.ru/news/1115-rezident-fonda-skolkovo-pomozhet-propisat-pravilnoe-lekarstvo.html</loc></url><url><loc>https://market-access-solutions.ru/news/1119-cennostno-orientirovannaya-ocenka-medicinskih-tehnologiy.html</loc></url><url><loc>https://market-access-solutions.ru/news/1121-obraschenie-medicinskih-izdeliy-na-territorii-rf.html</loc></url><url><loc>https://market-access-solutions.ru/news/1127-konferenciya-gosudarstvennoe-regulirovanie-i-rossiyskaya-farmpromyshlennost-2015-prodolzhenie-dialoga-stanet-ploschadkoy-dlya-obsuzhdeniya-voprosa-regulirovaniya-cen-na-zhiznenno-vazhnye.html</loc></url><url><loc>https://market-access-solutions.ru/news/1130-minzdrav-razrabotal-metodiku-rascheta-predelnyh-cen-na-medizdeliya.html</loc></url><url><loc>https://market-access-solutions.ru/news/1133-2-ya-mezhdunarodnaya-konferenciya-na-temu-dokazatelnaya-medicina-ot-teorii-k-praktike.html</loc></url><url><loc>https://market-access-solutions.ru/news/1137-seminar-zakupka-lekarstvennyh-sredstv-dlya-gosudarstvennyh-i-municipalnyh-nuzhd-pravovye-i-kommunikacionnye-aspekty.html</loc></url><url><loc>https://market-access-solutions.ru/news/1156-rnc-pharma-predstavlyaet-obnovlenie-bd-import-lekarstv-v-rossiyu-po-itogam-fevralya-2015-g.html</loc></url><url><loc>https://market-access-solutions.ru/news/1168-s-1-iyulya-2015-goda-farmakonadzor-polnostyu-pereydet-pod-kontrol-roszdravnadzora.html</loc></url><url><loc>https://market-access-solutions.ru/news/1175-centr-monitoringa-i-kliniko-ekonomicheskoy-ekspertizy-roszdravnadzora-ekspertiza-obrazovanie-konsultacii.html</loc></url><url><loc>https://market-access-solutions.ru/news/1189-fts-soobschaet-o-sokraschenii-obema-importa-lekarstvennyh-preparatov-v-rf.html</loc></url><url><loc>https://market-access-solutions.ru/news/1198-problema-ozhireniya-i-izbytochnoy-massy-tela-v-rossii.html</loc></url><url><loc>https://market-access-solutions.ru/news/1205-pravitelstvo-opredelilo-poryadok-izmeneniya-usloviy-kontrakta-po-provedeniyu-klinicheskih-issledovaniy-lekarstv.html</loc></url><url><loc>https://market-access-solutions.ru/news/1207-klinvest-centr-apteka-novosti-farmacii-mas-genetika.html</loc></url><url><loc>https://market-access-solutions.ru/news/1210-finansirovanie-zdravoohraneniya-v-rf.html</loc></url><url><loc>https://market-access-solutions.ru/news/1216-pravitelstvo-utverdilo-rasporyazheniya-ob-uluchshenii-lekarstvennogo-obespecheniya.html</loc></url><url><loc>https://market-access-solutions.ru/news/1219-rasshiryaya-nomenklaturu-postanovleniy.html</loc></url><url><loc>https://market-access-solutions.ru/news/1220-farmpreparaty-rossiyskogo-proizvodstva-zaymut-polovinu-vnutrennego-rynka-lekarstv-k-2020-godu.html</loc></url><url><loc>https://market-access-solutions.ru/news/1223-klinicist-ekonomist-issledovatel-tri-v-odnom.html</loc></url><url><loc>https://market-access-solutions.ru/news/1224-fas-opredelila-kriterii-provedeniya-igrokov-zanimayuschih-dominiruyuschee-polozhenie-na-rynke-ls.html</loc></url><url><loc>https://market-access-solutions.ru/news/1225-iz-byudzheta-budut-vydeleny-dopolnitelnye-sredstva-na-programmu-sem-nozologiy.html</loc></url><url><loc>https://market-access-solutions.ru/news/1226-rosstat-otmechaet-rost-cen-na-medikamenty.html</loc></url><url><loc>https://market-access-solutions.ru/news/1227-v-pervom-polugodii-2015-goda-v-rossii-bylo-proizvedeno-medizdeliy-na-summu-137-mlrd-rubley.html</loc></url><url><loc>https://market-access-solutions.ru/news/1228-rynok-bioanalogov-k-2020-godu-mozhet-dostignut-55-mlrd-dollarov-ssha.html</loc></url><url><loc>https://market-access-solutions.ru/news/1229-minpromtorg-razrabotal-reglament-o-vydache-zaklyucheniya-o-sootvetstvii-proizvodstva-preparata-pravilam-gpp.html</loc></url><url><loc>https://market-access-solutions.ru/news/1230-rosstat-otmechaet-rost-proizvodstva-farmprodukcii-v-pervom-polugodii-2015-goda.html</loc></url><url><loc>https://market-access-solutions.ru/news/1231-prezident-obyazal-regiony-soglasovyvat-nadbavki-na-zhnvlp.html</loc></url><url><loc>https://market-access-solutions.ru/news/1232-gosduma-rabotaet-nad-novym-zakonom-ob-importozameschenii-originalnyh-lekarstvennyh-preparatov.html</loc></url><url><loc>https://market-access-solutions.ru/news/1235-logisticheskie-kompanii-obsluzhivayuschie-klinicheskie-ispytaniya-prosyat-lgot-na-tamozhne.html</loc></url><url><loc>https://market-access-solutions.ru/news/1237-minpromtorg-predlozhil-schitat-upakovannye-v-rossii-lekarstva-otechestvennym-produktom-do-2016-goda.html</loc></url><url><loc>https://market-access-solutions.ru/news/1239-xvii-ezhegodnaya-vserossiyskaya-konferenciya-gosudarstvennoe-regulirovanie-v-sfere-obrascheniya-lekarstvennyh-sredstv-i-medicinskih-izdeliy-farmmedobraschenie-2015.html</loc></url><url><loc>https://market-access-solutions.ru/news/1244-fas-podgotovila-razyasneniya-o-poryadke-registracii-cen-na-zhiznenno-vazhnye-preparaty.html</loc></url><url><loc>https://market-access-solutions.ru/news/1246-v-rossii-za-pervye-s-yanvarya-po-iyul-bylo-proizvedeno-medizdeliy-na-summu-162-mlrd-dollarov-ssha.html</loc></url><url><loc>https://market-access-solutions.ru/news/1257-roszdravnadzor-mozhet-voyti-v-sostav-rospotrebnadzora.html</loc></url><url><loc>https://market-access-solutions.ru/news/1259-farmkompanii-zhdut-ustraneniya-pravovoy-neopredelennosti-pri-registracii-cen-na-zhnvlp-na-2016-god.html</loc></url><url><loc>https://market-access-solutions.ru/news/1262-x-nauchno-prakticheskiy-kongress-s-mezhdunarodnym-uchastiem-racionalnaya-farmakoterapiya-2015.html</loc></url><url><loc>https://market-access-solutions.ru/news/1263-reklama-lekarstvennyh-sredstv-mirovye-praktiki-zapret-svoboda-ili-chto-to-mezhdu-nimi.html</loc></url><url><loc>https://market-access-solutions.ru/news/1273-minekonomrazvitiya-predlagaet-ustanovit-srok-raschetov-po-goskontraktam.html</loc></url><url><loc>https://market-access-solutions.ru/news/1274-s-1-oktyabrya-obnovlyaetsya-poryadok-registracii-predelnyh-otpusknyh-cen-na-preparaty-iz-perechnya-zhnvlp.html</loc></url><url><loc>https://market-access-solutions.ru/news/1275-programma-xvii-vserossiyskoy-konferencii-gosudarstvennoe-regulirovanie-v-sfere-obrascheniya-lekarstvennyh-sredstv-i-medicinskih-izdeliy-farmmedobraschenie-2015.html</loc></url><url><loc>https://market-access-solutions.ru/news/1276-izmenena-metodika-rascheta-predelnyh-cen-na-preparaty-iz-perechnya-zhnvlp.html</loc></url><url><loc>https://market-access-solutions.ru/news/1279-yabloko-razdora-marketingovye-dogovora-antimonopolnaya-praktika-es.html</loc></url><url><loc>https://market-access-solutions.ru/news/1281-eek-razrabotala-pravila-provedeniya-issledovaniy-biologicheskih-lekarstv-v-eaes.html</loc></url><url><loc>https://market-access-solutions.ru/news/1295-partnery-rossii-po-eaes-poka-ne-gotovy-predostavit-preferencii-dlya-lokalnyh-proizvoditeley.html</loc></url><url><loc>https://market-access-solutions.ru/news/1305-minzdrav-predlagaet-uvelichit-razmer-gosudarstvennoy-pomoschi-na-lekarstvennye-preparaty.html</loc></url><url><loc>https://market-access-solutions.ru/news/1307-minzdrav-razrabotal-formu-zayavleniya-o-registracii-ili-pereregistracii-predelnoy-otpusknoy-ceny-na-zhnvlp.html</loc></url><url><loc>https://market-access-solutions.ru/news/1308-minpromtorg-prinyal-20-planov-importozamescheniya-po-vsem-klyuchevym-otraslyam-promyshlennosti.html</loc></url><url><loc>https://market-access-solutions.ru/news/1309-v-fas-sozdan-otdel-regulirovaniya-cen-na-lekarstvennye-preparaty.html</loc></url><url><loc>https://market-access-solutions.ru/news/1310-planiruemye-rashody-iz-federalnogo-byudzheta-na-zdravoohranenie-na-2016-god.html</loc></url><url><loc>https://market-access-solutions.ru/news/1321-minzdrav-rossii-razrabatyvaet-formu-zayavleniya-o-registracii-ili-pereregistracii-predelnoy-otpusknoy-ceny-proizvoditelya-na-zhnvlp.html</loc></url><url><loc>https://market-access-solutions.ru/news/1323-ekspert-pravila-formirovaniya-perechney-lekarstv-nado-priblizit-k-realnosti.html</loc></url><url><loc>https://market-access-solutions.ru/news/1324-market-access-specialisty-po-dostupu-vne-dostupa.html</loc></url><url><loc>https://market-access-solutions.ru/news/1333-ustanovlen-poryadok-opredeleniya-vzaimozamenyaemosti-lekarstvennyh-preparatov.html</loc></url><url><loc>https://market-access-solutions.ru/news/1338-do-konca-tekuschego-goda-v-gosdumu-planiruetsya-vnesti-zakonoproekt-reguliruyuschiy-obraschenie-medizdeliy.html</loc></url><url><loc>https://market-access-solutions.ru/news/1345-pravitelstvo-utverdilo-pravila-monitoringa-goszakupok.html</loc></url><url><loc>https://market-access-solutions.ru/news/1346-razrabotany-tipovye-usloviya-kontrakta-na-postavku-lekarstvennyh-sredstv.html</loc></url><url><loc>https://market-access-solutions.ru/news/1348-fas-rossii-razyasnyaet-poryadok-formirovaniya-otpusknoy-ceny-na-zhnvlp-v-zavisimosti-ot-primenyaemoy-sistemy-nalogooblozheniya.html</loc></url><url><loc>https://market-access-solutions.ru/news/1359-v-rossii-razvivaetsya-kontraktnoe-proizvodstvo-lekarstvennyh-sredstv.html</loc></url><url><loc>https://market-access-solutions.ru/news/1363-pravitelstvo-vnosit-popravki-v-poryadok-zaklyucheniya-dolgosrochnyh-goskontraktov.html</loc></url><url><loc>https://market-access-solutions.ru/news/1371-murzabaeva-prezident-oboznachil-aktualnye-problemy-zdravoohraneniya.html</loc></url><url><loc>https://market-access-solutions.ru/news/1372-analiz-dannyh-po-bolee-chem.html</loc></url><url><loc>https://market-access-solutions.ru/news/1373-ekspert-pacientov-ne-dolzhno-interesovat-otkuda-gosudarstvo-vozmet-dengi-na-lekarstva.html</loc></url><url><loc>https://market-access-solutions.ru/news/1374-odobren-zakonoproekt-o-ratifikacii-soglasheniya-o-edinyh-principah-i-pravilah-obrascheniya-lekarstvennyh-sredstv-v-ramkah-eaes.html</loc></url><url><loc>https://market-access-solutions.ru/news/1375-edinye-pravila-obrascheniya-lekarstvennyh-preparatov-na-rynke-eaes-dolzhno-privesti-k-snizheniyu-cen-na-nih.html</loc></url><url><loc>https://market-access-solutions.ru/news/1376-ekspert-regiony-ne-poluchat-specialnyh-sredstv-dlya-bolnyh-orfannymi-zabolevaniyami.html</loc></url><url><loc>https://market-access-solutions.ru/news/1377-postanovlenie-tretiy-lishniy-uskorit-importozameschenie.html</loc></url><url><loc>https://market-access-solutions.ru/news/1378-gosduma-odobrila-v-pervom-chtenii-zakonoproekt-ob-uvelichenii-zatrat-na-zakupku-ls-dlya-lgotnyh-kategoriy-grazhdan.html</loc></url><url><loc>https://market-access-solutions.ru/news/1380-pozdravlyaem-vas-s-nastupayuschim-novym-godom-i-rozhdestvom.html</loc></url><url><loc>https://market-access-solutions.ru/news/1383-pravitelstvo-rf-prizvali-peresmotret-perechen-orfannyh-zabolevaniy.html</loc></url><url><loc>https://market-access-solutions.ru/news/140-nikolay-gerasimenko-predlozhil-vvesti-testirovanie-medstandartov.html</loc></url><url><loc>https://market-access-solutions.ru/news/1400-podpisano-postanovlenie-o-gosregulirovanii-cen-na-medizdeliya-implantiruemye-v-organizm-cheloveka.html</loc></url><url><loc>https://market-access-solutions.ru/news/1401-obem-rynka-preparatov-dlya-lecheniya-raka-zheludka-v-2024-godu-sostavit-44-mlrd-dollarov-ssha.html</loc></url><url><loc>https://market-access-solutions.ru/news/1405-v-2016-godu-budut-vneseny-izmeneniya-v-trebovaniya-k-instrukciyam-lekarstvennyh-preparatov.html</loc></url><url><loc>https://market-access-solutions.ru/news/1409-v-2016-g-inostrannym-farmkompaniyam-dlya-pereregistracii-lekarstv-ne-nuzhno-prohodit-rossiyskiy-inspektorat.html</loc></url><url><loc>https://market-access-solutions.ru/news/1410-analitiki-registraciyu-lekarstv-v-rossii-nuzhno-sovershenstvovat.html</loc></url><url><loc>https://market-access-solutions.ru/news/1412-eksperty-farmrynka-ocenili-perspektivy-ego-razvitiya-v-2016-godu.html</loc></url><url><loc>https://market-access-solutions.ru/news/1418-skvorcova-rasshirenie-spiska-vazhnyh-lekarstv-pozvolit-vlasti-derzhat-pod-kontrolem-ceny.html</loc></url><url><loc>https://market-access-solutions.ru/news/1420-analitiki-prognoziruyut-rost-mirovogo-ots-rynka.html</loc></url><url><loc>https://market-access-solutions.ru/news/1421-v-2015-godu-uvelichilos-chislo-zhalob-svyazannyh-s-lekarstvennym-obespecheniem.html</loc></url><url><loc>https://market-access-solutions.ru/news/1422-ceny-na-lekarstvennye-preparaty-v-yanvare-2016-goda-vyrosli-na-05.html</loc></url><url><loc>https://market-access-solutions.ru/news/1423-apteki-i-seti-v-kontekste-form-sobstvennosti-ocherk-mirovyh-trendov.html</loc></url><url><loc>https://market-access-solutions.ru/news/1424-tfoms-mogut-vernut-funkcii-strahovyh-medicinskih-kompaniy.html</loc></url><url><loc>https://market-access-solutions.ru/news/1425-pravitelstvo-gotovo-dopolnitelno-vydelit-15-20-mlrd-rubley-na-zakupku-lekarstv.html</loc></url><url><loc>https://market-access-solutions.ru/news/1426-sovet-federacii-ratificiroval-soglasheniya-o-edinyh-pravilah-obrascheniya-ls-i-medizdeliy-v-eaes.html</loc></url><url><loc>https://market-access-solutions.ru/news/1427-minzdrav-izmenit-sistemu-zakupok-lekarstv-ot-vich.html</loc></url><url><loc>https://market-access-solutions.ru/news/1429-rynok-vakcin-budet-uvelichivatsya-na-12-v-god.html</loc></url><url><loc>https://market-access-solutions.ru/news/1434-minpromtorg-gosudarstvu-pora-perestat-regulirovat-ceny-na-deshevye-lekarstva.html</loc></url><url><loc>https://market-access-solutions.ru/news/1435-minzdrav-snova-zayavil-o-nedopustimosti-otmeny-gosregulirovaniya-cen-na-zhnvlp.html</loc></url><url><loc>https://market-access-solutions.ru/news/1437-dmitriy-medvedev-model-edinstvennogo-postavschika-dolzhna-primenyatsya-tolko-v-sluchayah-kogda-bez-nego-nevozmozhno-oboytis.html</loc></url><url><loc>https://market-access-solutions.ru/news/1449-fas-podgotovila-zakonoproekt-dlya-prinuditelnogo-licenzirovaniya-socialno-znachimyh-tovarov.html</loc></url><url><loc>https://market-access-solutions.ru/news/1453-minpromtorg-vyskazyvaet-opaseniya-po-povodu-prinuditelnogo-licenzirovaniya.html</loc></url><url><loc>https://market-access-solutions.ru/news/1455-minzdrav-planiruet-izmenit-poryadok-finansirovaniya-vmp.html</loc></url><url><loc>https://market-access-solutions.ru/news/1458-gosduma-rassmotrit-zakonoproekt-o-kompensacii-rashodov-na-lekarstva-dlya-lgotnyh-kategoriy-grazhdan.html</loc></url><url><loc>https://market-access-solutions.ru/news/1466-v-2016-godu-v-spisok-zhnvlp-voshlo-646-preparatov.html</loc></url><url><loc>https://market-access-solutions.ru/news/1470-fas-opublikovala-predelnye-razmery-optovyh-i-roznichnyh-nadbavok-k-cenam-na-zhiznenno-neobhodimye-i-vazhneyshie-lekarstvennye-preparaty.html</loc></url><url><loc>https://market-access-solutions.ru/news/1472-fas-predlagaet-izmenit-pravila-ustanovleniya-predelnyh-razmerov-nadbavok-k-cenam-na-zhnvlp.html</loc></url><url><loc>https://market-access-solutions.ru/news/1475-fas-legalizaciya-parallelnogo-importa-pozvolit-uluchshit-konkurentnuyu-sredu-na-rynke.html</loc></url><url><loc>https://market-access-solutions.ru/news/1481-senatory-predlagayut-likvidirovat-foms.html</loc></url><url><loc>https://market-access-solutions.ru/news/1482-roza-yagudina-lechit-neeffektivnymi-preparatami-ochen-dorogo.html</loc></url><url><loc>https://market-access-solutions.ru/news/1483-ekspert-v-perechne-zhnvlp-ochen-mnogo-ustarevshih-preparatov.html</loc></url><url><loc>https://market-access-solutions.ru/news/1484-minzdrav-rf-razrabotal-zakonoproekt-po-vozmescheniyu-chasti-zatrat-na-lekarstva.html</loc></url><url><loc>https://market-access-solutions.ru/news/1485-farmkompanii-dolzhny-by-uvedomlyat-minzdrav-o-vyvode-preparata-s-rynka.html</loc></url><url><loc>https://market-access-solutions.ru/news/1486-obem-farmacevticheskogo-rynka-rossii-v-2015-godu-dostig-1-259-mlrd-rubley.html</loc></url><url><loc>https://market-access-solutions.ru/news/1488-minzdrav-razrabotal-reglament-po-registracii-predelnyh-cen-na-implantaty.html</loc></url><url><loc>https://market-access-solutions.ru/news/1489-pravitelstvennaya-komissiya-odobrila-zakonoproekt-o-shtrafah-za-zavyshenie-cen-na-lekarstva.html</loc></url><url><loc>https://market-access-solutions.ru/news/1490-obespechenie-dostupnosti-lekarstv-dlya-naseleniya-rf-bezuslovnyy-prioritet-dlya-farmindustrii.html</loc></url><url><loc>https://market-access-solutions.ru/news/1493-press-konferenciya-finansirovanie-lecheniya-pacientov-s-redkimi-zabolevaniyami-v-ramkah-antikrizisnogo-plana-pravitelstva-rossiyskoy-federacii-plan-podderzhki-ekonomiki-2016-g.html</loc></url><url><loc>https://market-access-solutions.ru/news/15-pochemu-rossiyane-ne-mogut-nadeyatsya-na-kachestvennuyu-medicinskuyu-pomosch-ni-v-gosudarstvennyh-ni-v-chastnyh-klinikah.html</loc></url><url><loc>https://market-access-solutions.ru/news/1500-v-rossii-vpervye-za-vosem-let-upali-prodazhi-lekarstvennyh-preparatov.html</loc></url><url><loc>https://market-access-solutions.ru/news/1504-v-mae-import-farmacevticheskoy-produkcii-v-rf-sokratilsya-na-46.html</loc></url><url><loc>https://market-access-solutions.ru/news/1505-minpromtorg-rossii-podvel-itogi-deyatelnosti-otrasli-farmmedproma-v-2015-godu.html</loc></url><url><loc>https://market-access-solutions.ru/news/1507-razrabotan-administrativnyy-reglament-po-gosnadzoru-za-obrascheniem-lekarstv.html</loc></url><url><loc>https://market-access-solutions.ru/news/1511-import-veterinarnyh-preparatov-prakticheski-ne-postradal-ot-devalvacii-rublya.html</loc></url><url><loc>https://market-access-solutions.ru/news/1514-zachem.html</loc></url><url><loc>https://market-access-solutions.ru/news/1517-farmacevticheskiy-rynok-rossii-analiticheskiy-obzor-po-itogam-aprelya-2016-g.html</loc></url><url><loc>https://market-access-solutions.ru/news/1518-manturov-v-2015-godu-za-schet-gospodderzhki-poyavilos-29-novyh-lekarstv.html</loc></url><url><loc>https://market-access-solutions.ru/news/1528-minpromtorg-i-minzdrav-utverdili-perechen-biomisheney.html</loc></url><url><loc>https://market-access-solutions.ru/news/1530-za-1-kvartal-2016-goda-po-programme-llo-bylo-zakupleno-ls-na-summu-426-mlrd-rubley.html</loc></url><url><loc>https://market-access-solutions.ru/news/1539-gupy-i-mupy-budut-zakupat-lekarstva-po-kontraktnoy-sisteme.html</loc></url><url><loc>https://market-access-solutions.ru/news/1540-prokuratura-sovmestno-s-drugimi-gosorganami-budet-presekat-narusheniya-pri-goskazupkah-lekarstv-i-medizdeliy.html</loc></url><url><loc>https://market-access-solutions.ru/news/1544-vyshel-v-svet-zhurnal-farmakogenetika-i-farmakogenomika-1-2016-g.html</loc></url><url><loc>https://market-access-solutions.ru/news/1547-nauchno-prakticheskaya-konferenciya-sovremennye-aspekty-profilaktiki-diagnostiki-i-lecheniya-vich-infekcii.html</loc></url><url><loc>https://market-access-solutions.ru/news/1565-raziet-natho-vozmozhnosti-regionov-po-lekobespecheniyu-pacientov-s-orfannymi-zabolevaniyami-ischerpany.html</loc></url><url><loc>https://market-access-solutions.ru/news/1570-denis-manturov-vnes-predlozheniya-po-podderzhke-otechestvennyh-proizvoditeley-farmacevticheskoy-produkcii.html</loc></url><url><loc>https://market-access-solutions.ru/news/1572-import-lekarstvennyh-preparatov-v-rossiyu-snizilsya-na-85.html</loc></url><url><loc>https://market-access-solutions.ru/news/1574-xviii-ezhegodnaya-vserossiyskaya-konferenciya-gosudarstvennoe-regulirovanie-v-sfere-obrascheniya-lekarstvennyh-sredstv-i-medicinskiy-izdeliy-farmmedobraschenie-2016.html</loc></url><url><loc>https://market-access-solutions.ru/news/1577-vyshel-v-svet-zhurnal-farmakokinetika-i-farmakodinamika-1-2016-g.html</loc></url><url><loc>https://market-access-solutions.ru/news/1587-v-programmu-farma-2020-vlozheno-50-mlrd-rubley.html</loc></url><url><loc>https://market-access-solutions.ru/news/1597-v-moskve-sostoyalsya-kruglyy-stol-posvyaschennyy-voprosam-cenoobrazovaniya.html</loc></url><url><loc>https://market-access-solutions.ru/news/1598-minzdrav-razrabotal-prikaz-ob-utverzhdenii-administrativnogo-reglamenta-po-vydache-zaklyucheniy-na-vvoz-i-vyvoz-organov-i-tkaney-cheloveka-krovi-i-ee-komponentov-a-takzhe-obrazcov-biologicheskih.html</loc></url><url><loc>https://market-access-solutions.ru/news/160-na-segodnyashniy-den-net-neobhodimosti-toropitsya-s-prinyatiem-syrogo-zakona-ob-obraschenii-medicinskih-izdeliy.html</loc></url><url><loc>https://market-access-solutions.ru/news/1608-minzdrav-prorabotaet-vopros-o-cenah-na-zhiznenno-neobhodimye-lekarstva.html</loc></url><url><loc>https://market-access-solutions.ru/news/161-minzdrav-rossii-i-evropeyskaya-komissiya-po-voprosam-zdravoohraneniya-proveli-sovmestnoe-zasedanie.html</loc></url><url><loc>https://market-access-solutions.ru/news/162-minpromtorg-provodit-nezavisimuyu-ekspertizu-zakona-ob-obraschenii-medicinskih-izdeliy.html</loc></url><url><loc>https://market-access-solutions.ru/news/1624-import-gotovyh-lp-v-rossiyu-po-itogam-iyulya-2016-goda-stagniruet.html</loc></url><url><loc>https://market-access-solutions.ru/news/163-medvedev-soobschil-o-snizhenii-rosta-cen-na-lekarstva.html</loc></url><url><loc>https://market-access-solutions.ru/news/1639-fas-nastaivaet-na-prinuditelnoy-peredache-patentov-na-lekarstva.html</loc></url><url><loc>https://market-access-solutions.ru/news/164-skvorcova-poobeschala-desyatikratnoe-uvelichenie-palliativnyh-koek-v-stacionarah-strany.html</loc></url><url><loc>https://market-access-solutions.ru/news/1640-izmeneniya-i-perspektivy-farmacevticheskogo-zakonodatelstva-v-2016-godu.html</loc></url><url><loc>https://market-access-solutions.ru/news/1642-rosstat-v-yanvare-avguste-v-rossii-proizvedeno-medizdeliy-na-summu-214-mlrd-rubley.html</loc></url><url><loc>https://market-access-solutions.ru/news/1643-eksperty-rekomendovali-ne-vklyuchat-novye-lekarstva-ot-vich-v-perechen-zhiznenno-vazhnyh.html</loc></url><url><loc>https://market-access-solutions.ru/news/1646-to-chto-doktor-propisal.html</loc></url><url><loc>https://market-access-solutions.ru/news/1647-alternativnye-metody-zakupki-povyshayut-dostupnost-lekarstv-i-ekonomyat-sredstva.html</loc></url><url><loc>https://market-access-solutions.ru/news/165-uvelichen-normativ-po-obespecheniyu-lekarstvennymi-preparatami.html</loc></url><url><loc>https://market-access-solutions.ru/news/1650-podgotovlen-zakon-obyazuyuschiy-proizvoditeley-lekarstv-poluchit-u-roszdravnadzora-specialnoe-razreshenie-dlya-ih-dopuska-na-rynok.html</loc></url><url><loc>https://market-access-solutions.ru/news/1651-veronika-skvorcova-predlagaet-izmenit-cenoobrazovanie-pri-goszakupkah-lekarstv.html</loc></url><url><loc>https://market-access-solutions.ru/news/1652-ogranichitelnye-spiski-lekarstv-neobhodimo-sovershenstvovat.html</loc></url><url><loc>https://market-access-solutions.ru/news/1653-rossiyskim-tovaram-i-uslugam-otdan-prioritet-pri-goszakupkah.html</loc></url><url><loc>https://market-access-solutions.ru/news/1654-post-reliz-iii-mezhdunarodnoy-nauchno-prakticheskoy-konferencii-ocenka-tehnologiy-zdravoohraneniya-vnedrenie-innovacionnyh-tehnologiy.html</loc></url><url><loc>https://market-access-solutions.ru/news/1655-byudzhet-na-centralizovannye-zakupki-lekarstv-v-sleduyuschem-godu-sokraschatsya-ne-budet.html</loc></url><url><loc>https://market-access-solutions.ru/news/1656-otmena-gosregulirovaniya-cen-na-deshevye-lekarstva-pravitelstvom-ne-rassmatrivaetsya.html</loc></url><url><loc>https://market-access-solutions.ru/news/1657-timofey-nizhegorodcev-komissiya-po-sostavleniyu-perechnya-zhnvlp-dolzhna-rabotat-postoyanno.html</loc></url><url><loc>https://market-access-solutions.ru/news/1658-obedinenie-vedomstv-obsuzhdaetsya-v-ramkah-optimizacii-ih-struktur-dlya-povysheniya-kachestva-gosnadzora-i-kontrolya.html</loc></url><url><loc>https://market-access-solutions.ru/news/1659-eek-reshenie-o-vydache-regudostovereniya-lp-ne-zavisit-ot-opredeleniya-vzaimozamenyaemosti.html</loc></url><url><loc>https://market-access-solutions.ru/news/166-rossiyskie-eksperty-rasskazali-kak-povysit-effektivnost-lecheniya-psihicheskih-rasstroystv.html</loc></url><url><loc>https://market-access-solutions.ru/news/1660-minfin-sokraschaet-rashody-na-zdravoohranenie-i-obrazovanie.html</loc></url><url><loc>https://market-access-solutions.ru/news/1661-obem-importa-lekarstvennyh-preparatov-v-sentyabre-2016-goda-sostavil-7947-mln-dollarov-ssha.html</loc></url><url><loc>https://market-access-solutions.ru/news/1663-regulyatornye-organy-vedut-peregovory-ob-umenshenii-stoimosti-lp.html</loc></url><url><loc>https://market-access-solutions.ru/news/1664-razrabotan-proekt-federalnogo-zakona-o-byudzhete-ffoms-na-2017-god-i-na-planovyy-period-2018-i-2019.html</loc></url><url><loc>https://market-access-solutions.ru/news/1668-direktor-departamenta-elena-maksimkina-prinyala-uchastie-v-konferencii-ocenka-tehnologiy-zdravoohraneniya-vnedrenie-innovacionnyh-tehnologiy.html</loc></url><url><loc>https://market-access-solutions.ru/news/1680-sovet-federacii-podderzhit-sistemu-ocenki-medicinskih-tehnologiy.html</loc></url><url><loc>https://market-access-solutions.ru/news/1692-za-pervye-devyat-mesyacev-2016-goda-v-rossiyu-bylo-vvezeno-importnyh-lekarstvennyh-preparatov-na-summu-4237-mlrd-rubley.html</loc></url><url><loc>https://market-access-solutions.ru/news/1700-v-2017-godu-vpervye-snizitsya-finansirovanie-programmy-sem-nozologiy.html</loc></url><url><loc>https://market-access-solutions.ru/news/1704-do-konca-goda-obem-rossiyskogo-farmrynka-uvelichitsya-na-10.html</loc></url><url><loc>https://market-access-solutions.ru/news/1708-za-pervye-devyat-mesyacev-tekuschego-goda-v-aptekah-bylo-prodano-diagnosticheskih-priborov-na-summu-10-mlrd-rubley.html</loc></url><url><loc>https://market-access-solutions.ru/news/1709-v-2017-godu-vpervye-snizitsya-finansirovanie-semi-nozologiy.html</loc></url><url><loc>https://market-access-solutions.ru/news/171-s-2013-goda-pozhilye-lyudi-smogut-ne-rezhe-odnogo-raza-v-tri-goda-prohodit-medobsledovanie.html</loc></url><url><loc>https://market-access-solutions.ru/news/1711-perechen-medicinskih-izdeliy-implantiruemyh-v-organizm-cheloveka-dopolnen-160-vidami-medicinskih-izdeliy.html</loc></url><url><loc>https://market-access-solutions.ru/news/1714-prioritet-pri-goszakupkah-budet-otdan-lp-proizvedennym-v-rossii-po-polnomu-ciklu.html</loc></url><url><loc>https://market-access-solutions.ru/news/172-evropeyskie-instituty-ekspertizy-medicinskih-tehnologiy-ekonomyat-byudzhety-zdravoohraneniya.html</loc></url><url><loc>https://market-access-solutions.ru/news/1720-odobren-zakonoproekt-obyazyvayuschiy-uchastnikov-zakupok-dokazyvat-vozmozhnost-ispolneniya-kontrakta-po-predlozhennoy-cene.html</loc></url><url><loc>https://market-access-solutions.ru/news/1728-importozameschenie-postepenno-menyaet-rynok-lekarstv-i-medizdeliy.html</loc></url><url><loc>https://market-access-solutions.ru/news/1729-russian-pharma-awards-2016-vrachi-vybrali-luchshih.html</loc></url><url><loc>https://market-access-solutions.ru/news/1730-komissiya-po-zakonoproektnoy-deyatelnosti-odobrila-zakonoproekt-napravlennyy-na-sovershenstvovanie-poryadka-provedeniya-konkursov-i-aukcionov-pri-goszakupkah.html</loc></url><url><loc>https://market-access-solutions.ru/news/1732-reshenie-soveta-evraziyskoy-ekonomicheskoy-komissii-o-priznanii-rezultatov-inspektirovaniya-proizvodstva-lekarstvennyh-sredstv.html</loc></url><url><loc>https://market-access-solutions.ru/news/1736-rossiya-potratila-na-lgotnye-lekarstva-895-mlrd-rubley.html</loc></url><url><loc>https://market-access-solutions.ru/news/1739-normy-dokumentov-eaes-napravleny-na-povyshenie-konkurentosposobnosti-proizvodimyh-medizdeliy.html</loc></url><url><loc>https://market-access-solutions.ru/news/1743-novoe-v-zakonodatelstve-v-sfere-zdravoohraneniya.html</loc></url><url><loc>https://market-access-solutions.ru/news/1753-pri-gosdume-sozdan-sovet-po-razvitiyu-biotehnologiy-farmacevticheskoy-i-medicinskoy-promyshlennosti.html</loc></url><url><loc>https://market-access-solutions.ru/news/1756-import-lekarstvennyh-preparatov-za-11-mesyacev-2016-goda-sostavil-4421-mlrd-rubley.html</loc></url><url><loc>https://market-access-solutions.ru/news/1759-fas-ceny-na-preparaty-po.html</loc></url><url><loc>https://market-access-solutions.ru/news/1760-minzdrav-razrabotal-proekt-postanovleniya-ob-osuschestvlenii-goskontrolya-za-deyatelnostyu-v-sfere-obrascheniya-biomedicinskih-kletochnyh-produktov.html</loc></url><url><loc>https://market-access-solutions.ru/news/1768-minpromtorg-nameren-uprostit-registraciyu-v-rf-zarubezhnyh-preparatov.html</loc></url><url><loc>https://market-access-solutions.ru/news/1770-roszdravnadzor-budet-osuschestvlyat-registraciyu-medizdeliy-v-ramkah-evraziyskogo-ekonomicheskogo-soyuza.html</loc></url><url><loc>https://market-access-solutions.ru/news/1775-vyshel-v-svet-novyy-nomer-zhurnala-farmakokinetika-i-farmakodinamika-2016-g-3.html</loc></url><url><loc>https://market-access-solutions.ru/news/1776-pri-formirovanii-perechney-lekarstv-na-pervom-meste-klinicheskaya-effektivnost.html</loc></url><url><loc>https://market-access-solutions.ru/news/1785-v-2016-godu-obem-importa-lekarstvennyh-preparatov-v-rossiyu-sostavil-4931-mlrd-rubley.html</loc></url><url><loc>https://market-access-solutions.ru/news/1786-nauchno-prakticheskaya-konferenciya-ocenka-medicinskih-tehnologiy-dlya-orfannyh-zabolevaniy-16-fevralya-2017-g.html</loc></url><url><loc>https://market-access-solutions.ru/news/1788-v-2016-godu-v-rossiyu-bylo-vvezeno-vetpreparatov-na-summu-22-milliardov-rubley.html</loc></url><url><loc>https://market-access-solutions.ru/news/1791-regulyatornaya-informaciya.html</loc></url><url><loc>https://market-access-solutions.ru/news/1796-v-marte-aprele-v-rossii-budet-zapuschen-pilotnyy-proekt-po-vnedreniyu-modeli-risk-sheringa.html</loc></url><url><loc>https://market-access-solutions.ru/news/1799-obem-importa-farmprodukcii-v-yanvare-2017-goda-uvelichilsya-v-16-raza.html</loc></url><url><loc>https://market-access-solutions.ru/news/18-osnovnoy-problemoy-rossiyskoy-farmotrasli-yavlyaetsya-neblagopriyatnoe-zakonodatelstvo.html</loc></url><url><loc>https://market-access-solutions.ru/news/1800-v-yanvare-znachitelno-uvelichilsya-obem-importa-lekarstv.html</loc></url><url><loc>https://market-access-solutions.ru/news/1810-veronika-skvorcova-minzdrav-izmenit-podhody-k-goszakupkam-i-vnedrit-15-novyh-onkopreparatov.html</loc></url><url><loc>https://market-access-solutions.ru/news/1815-s-2011-goda-dolya-chastnyh-struktur-v-zdravoohranenii-vyrosla-na-20.html</loc></url><url><loc>https://market-access-solutions.ru/news/1816-preparaty-iz-spiska-zhnvlp-promarkiruyut-v-2018-godu.html</loc></url><url><loc>https://market-access-solutions.ru/news/1819-minzdrav-zadumalsya-o-rasshirenii-programmy-sem-nozologiy.html</loc></url><url><loc>https://market-access-solutions.ru/news/1831-obem-rossiyskogo-farmacevticheskogo-rynka-v-2016-godu-sostavil-12-trilliona-rubley.html</loc></url><url><loc>https://market-access-solutions.ru/news/1832-deputaty-eksperty-i-chinovniki-predlozhili-izmenit-zakonodatelstvo-po-lgotnomu-obespecheniyu-lekarstvami.html</loc></url><url><loc>https://market-access-solutions.ru/news/1834-vyshel-v-svet-zhurnal-farmakogenetika-i-farmakogenomika-2-2016.html</loc></url><url><loc>https://market-access-solutions.ru/news/1837-prinuditelnoe-licenzirovanie-ne-dolzhno-navredit-innovacionnoy-deyatelnosti-farmkompaniy.html</loc></url><url><loc>https://market-access-solutions.ru/news/1839-minekonomrazvitiya-podgotovit-zaklyuchenie-na-prinuditelnoe-licenzirovanie-lekarstv.html</loc></url><url><loc>https://market-access-solutions.ru/news/1840-glavnyy-genetik-minzdrava-predlozhil-rasshirit-perechen-24-nozologii.html</loc></url><url><loc>https://market-access-solutions.ru/news/1846-ob-izmeneniyah-v-poryadke-zakupki-lekarstv-dlya-lecheniya-redkih-zabolevaniy.html</loc></url><url><loc>https://market-access-solutions.ru/news/1847-import-lekarstv-v-rf-v-pervom-kvartale-2017-goda-uvelichilsya-na-87.html</loc></url><url><loc>https://market-access-solutions.ru/news/1852-ozhidaetsya-rost-farmacevticheskogo-rynka-v-2017-godu-kak-v-stoimostnom-tak-i-v-naturalnom-vyrazhenii.html</loc></url><url><loc>https://market-access-solutions.ru/news/1855-uchastniki-farmrynka-rf-prognoziruyut-ego-dalneyshiy-rost.html</loc></url><url><loc>https://market-access-solutions.ru/news/1857-minzdrav-poprosili-vklyuchit-immunodeficit-v-spisok-redkih-zabolevaniy.html</loc></url><url><loc>https://market-access-solutions.ru/news/1858-perechen-razrabatyvaemyh-dokumentov-dlya-raboty-edinogo-rynka-lekarstv-eaes.html</loc></url><url><loc>https://market-access-solutions.ru/news/1871-novoe-v-zakonodatelstve-v-sfere-zdravoohraneniya.html</loc></url><url><loc>https://market-access-solutions.ru/news/1873-vladimir-putin-podpisal-zakon-uproschayuschiy-rabotu-aptechnyh-gupov-i-mupov.html</loc></url><url><loc>https://market-access-solutions.ru/news/1878-zakonoproekt-o-telemedicine-prinyat-v-pervom-chtenii.html</loc></url><url><loc>https://market-access-solutions.ru/news/1889-sovetom-federacii-podderzhan-protokol-ob-eksporte-prinuditelno-licenzirovannyh-preparatov.html</loc></url><url><loc>https://market-access-solutions.ru/news/1890-xxiii-sezd-fiziologicheskogo-obschestva-im-i-p-pavlova.html</loc></url><url><loc>https://market-access-solutions.ru/news/1891-proizvodstvo-lekarstv-bez-identifikacionnyh-znakov-budet-zaprescheno-v-rossii.html</loc></url><url><loc>https://market-access-solutions.ru/news/1892-rossiyskie-proizvoditeli-poluchat-cenovye-preferencii-pri-goszakupkah.html</loc></url><url><loc>https://market-access-solutions.ru/news/1893-farm-i-medproizvodstvo-voshli-v-perechen-prioritetnyh-eksportnyh-otrasley.html</loc></url><url><loc>https://market-access-solutions.ru/news/1894-zakon-o-telemedicine-prinyat-v-okonchatelnom-chtenii.html</loc></url><url><loc>https://market-access-solutions.ru/news/1895-rasshiren-perechen-narkoticheskih-sredstv-i-psihoaktivnyh-veschestv-podlezhaschih-kontrolyu.html</loc></url><url><loc>https://market-access-solutions.ru/news/1896-ceny-na-lekarstvennye-preparaty-snizilis-v-iyule-na-05.html</loc></url><url><loc>https://market-access-solutions.ru/news/1897-kongress-s-mezhdunarodnym-uchastiem-dni-revmatologii-v-sankt-peterburge-2017.html</loc></url><url><loc>https://market-access-solutions.ru/news/1898-v-iyule-import-farmprodukcii-snizilsya-na-64.html</loc></url><url><loc>https://market-access-solutions.ru/news/190-s-ortopedicheskimi-implantatami-serf-dedienne-sante-risk-vyvihov-minimalen.html</loc></url><url><loc>https://market-access-solutions.ru/news/1906-kompaniya-merk-predstavila-svoy-vzglyad-na-organizaciyu-farmacevticheskih-proizvodstv-buduschego-na-ii-vserossiyskoy-gmp-konferencii.html</loc></url><url><loc>https://market-access-solutions.ru/news/1909-v-rossii-uvelichilsya-spros-na-sredstva-po-uhodu-za-bolnymi.html</loc></url><url><loc>https://market-access-solutions.ru/news/1913-obem-importa-lekarstvennyh-sredstv-v-rossiyu-uvelichilsya-na-39.html</loc></url><url><loc>https://market-access-solutions.ru/news/1922-predvaritelnye-itogi-realizacii-programmy-farma-2020-dolozheny-na-viii-sibirskom-mediko-farmacevticheskom-forume.html</loc></url><url><loc>https://market-access-solutions.ru/news/1930-russian-pharma-awards-2017-rossiyskie-vrachi-vybirayut-teva.html</loc></url><url><loc>https://market-access-solutions.ru/news/1932-za-desyat-mesyacev-tekuschego-goda-obem-otgruzok-preparatov-rossiyskih-farmproizvoditeley-sostavil-271-mlrd-rubley.html</loc></url><url><loc>https://market-access-solutions.ru/news/1934-eksport-rossiyskih-preparatov-za-desyat-mesyacev-tekuschego-goda-sostavil-167-mlrd-rubley.html</loc></url><url><loc>https://market-access-solutions.ru/news/1943-chto-ne-tak-s-pitaniem-v-lechebnyh-uchrezhdeniyah.html</loc></url><url><loc>https://market-access-solutions.ru/news/1945-prikaz-ob-utverzhdenii-poryadka.html</loc></url><url><loc>https://market-access-solutions.ru/news/1949-gosduma-rassmotrit-zakonoproekt-ob-uregulirovanii-voprosov-registracii-leksredstv.html</loc></url><url><loc>https://market-access-solutions.ru/news/1950-obem-vydelyaemyh-sredstv-na-zhnvlp-sostavlyaet-priblizitelno-05-trln-rubley.html</loc></url><url><loc>https://market-access-solutions.ru/news/1953-putin-podpisal-byudzhet-ffoms-na-2018-god.html</loc></url><url><loc>https://market-access-solutions.ru/news/1973-finansirovanie-programmy-sem-nozologiy-v-2018-g-ne-uvelichilos.html</loc></url><url><loc>https://market-access-solutions.ru/news/1974-aptechnye-seti-predupredili-o-vozmozhnom-roste-cen-na-preparaty.html</loc></url><url><loc>https://market-access-solutions.ru/news/1975-analitiki-prognoziruyut-rost-rynka-preparatov-dlya-lecheniya-sindroma-suhogo-glaza.html</loc></url><url><loc>https://market-access-solutions.ru/news/1977-konferenciya-rukovoditeley-medicinskih-uchrezhdeniy-zdravoohranenie-2018-izmeneniya-otrasli.html</loc></url><url><loc>https://market-access-solutions.ru/news/1978-mezhdunarodnyy-biomedicinskiy-sammit-2018-smbs-2018.html</loc></url><url><loc>https://market-access-solutions.ru/news/1979-o-problemah-intellektualnoy-sobstvennosti-na-lekarstvennom-rynke.html</loc></url><url><loc>https://market-access-solutions.ru/news/1980-razrabotany-izmeneniya-v-poryadok-provedeniya-klinicheskih-ispytaniy-medizdeliy.html</loc></url><url><loc>https://market-access-solutions.ru/news/1981-minzdrav-ozhidaet-uvelicheniya-ohvata-naseleniya-rf-lekarstvennoy-terapiey-v-2018-g-na-7-10.html</loc></url><url><loc>https://market-access-solutions.ru/news/199-na-realizaciyu-gosprogrammy-dostupnaya-sreda-v-regiony-budet-napravleno-bolee-340-millionov-rubley.html</loc></url><url><loc>https://market-access-solutions.ru/news/20-lpu-v-novyh-ekonomicheskih-usloviyah.html</loc></url><url><loc>https://market-access-solutions.ru/news/200-fst-razyasnyaet-voprosy-pereregistracii-cen-na-zhnvlp.html</loc></url><url><loc>https://market-access-solutions.ru/news/2006-igor-artemev-nalichie-antimonopolnogo-komplaensa-v-kompanii-dolzhno-byt-smyagchayuschim-obstoyatelstvom-pri-nalozhenii-shtrafov.html</loc></url><url><loc>https://market-access-solutions.ru/news/2015-specialist-po-registracii-lekarstvennyh-sredstv.html</loc></url><url><loc>https://market-access-solutions.ru/news/2016-roszdravnadzor-soobschaet-o-snizhenii-cen-na-preparaty-iz-perechnya-zhnvlp.html</loc></url><url><loc>https://market-access-solutions.ru/news/202-perspektivy-razvitiya-farmotrasli-rossii.html</loc></url><url><loc>https://market-access-solutions.ru/news/2024-import-aktivnyh-farmacevticheskih-ingredientov-v-yanvare-2018-goda.html</loc></url><url><loc>https://market-access-solutions.ru/news/203-povyshenie-priverzhennosti-lecheniyu-buduschee-za-elektronnymi-opovescheniyami.html</loc></url><url><loc>https://market-access-solutions.ru/news/2032-zakonoproekt-o-kontrsankciyah-v-otnoshenii-lekarstv-podderzhan-no-s-ogovorkami.html</loc></url><url><loc>https://market-access-solutions.ru/news/2038-deputaty-prinyali-zakon-uproschayuschiy-proceduru-gosregistracii-lekarstv.html</loc></url><url><loc>https://market-access-solutions.ru/news/204-novyy-patentnyy-rezhim-es.html</loc></url><url><loc>https://market-access-solutions.ru/news/2044-pravitelstvo-rf-uprostilo-pravila-gosudarstvennoy-registracii-medizdeliy.html</loc></url><url><loc>https://market-access-solutions.ru/news/2045-utverzhden-reglament-po-predostavleniyu-gosuslugi-po-akkreditacii-medorganizaciy-na-pravo-provedeniya-klinicheskih-issledovaniy-lekarstv.html</loc></url><url><loc>https://market-access-solutions.ru/news/205-direktor-po-prodazhe-informacionnyh-materialov-i-reklamnyh-ploschadey-v-medicinskih-zhurnalah.html</loc></url><url><loc>https://market-access-solutions.ru/news/2054-aleksandr-saverskiy-sobstvennyh-lekarstv-v-rossii-ne-bolshe-4.html</loc></url><url><loc>https://market-access-solutions.ru/news/2055-fas-rossii-biznesu-ne-nuzhno-opasatsya-parallelnogo-importa.html</loc></url><url><loc>https://market-access-solutions.ru/news/206-minzdrav-obyazhet-vrachey-vypisyvat-lekarstva-po-mnn.html</loc></url><url><loc>https://market-access-solutions.ru/news/2060-eksperty-otmechayut-rost-farmrynka-v-2017-godu.html</loc></url><url><loc>https://market-access-solutions.ru/news/2064-komitet-gd-po-ohrane-zdorovya-ne-podderzhal-zakonoproekt-ob-izmenenii-sroka-otmeny-gosregistracii-lekarstv.html</loc></url><url><loc>https://market-access-solutions.ru/news/2069-4-y-mezhdunarodnyy-forum-antikoagulyantnoy-i-antiagregantnoy-terapii-faktplus2019.html</loc></url><url><loc>https://market-access-solutions.ru/news/2070-vyvod-lekarstvennyh-sredstv-na-rynok-rossii-i-eaes-27-28-sentyabrya-moskva.html</loc></url><url><loc>https://market-access-solutions.ru/news/2071-forum-medicinskiy-i-farmacevticheskiy-biznes-20-sentyabrya-2018-goda-g-sankt-peterburg.html</loc></url><url><loc>https://market-access-solutions.ru/news/2072-dsm-group-v-2017-godu-bylo-prodano-zhiznenno-vazhnyh-preparatov-na-331-mlrd-rubley.html</loc></url><url><loc>https://market-access-solutions.ru/news/2073-obem-importa-veterinarnoy-produkcii-v-rf-sostavil-193-mlrd-rubley-za-pervye-chetyre-mesyaca-tekuschego-goda.html</loc></url><url><loc>https://market-access-solutions.ru/news/2074-vladimir-putin-poruchil-razrabotat-plan-meropriyatiy-po-opredeleniyu-vzaimozamenyaemosti-lekarstv.html</loc></url><url><loc>https://market-access-solutions.ru/news/2075-za-pervyy-kvartal-2018-goda-po-programme-lgotnogo-lekarstvennogo-obespecheniya-bylo-zakupleno-181-mln-upakovok-lekarstvennyh-sredstv-na-summu-146-mlrd-rubley.html</loc></url><url><loc>https://market-access-solutions.ru/news/2076-mezhdunarodnaya-konferenciya-realnyy-put-ot-nauchnyh-razrabotok-do-lekarstvennyh-sredstv.html</loc></url><url><loc>https://market-access-solutions.ru/news/2077-minzdrav-nameren-razrabotat-uskorennyy-mehanizm-vyvoda-na-rynok-proryvnyh-lekarstv.html</loc></url><url><loc>https://market-access-solutions.ru/news/2078-uproschenie-procedury-gosregistracii-medizdeliy-kompromiss-mezhdu-biznesom-i-regulyatorami.html</loc></url><url><loc>https://market-access-solutions.ru/news/2081-opredelena-otvetstvennost-za-narusheniya-v-sfere-biomedicinskih-kletochnyh-produktov.html</loc></url><url><loc>https://market-access-solutions.ru/news/2084-v-mae-obem-rossiyskogo-kommercheskogo-rynka-lekarstv-sostavil-77-mlrd-rubley.html</loc></url><url><loc>https://market-access-solutions.ru/news/2088-pravitelstvo-rf-uvelichilo-obem-subvenciy-na-lgotnoe-lekobespechenie.html</loc></url><url><loc>https://market-access-solutions.ru/news/2092-ceny-na-preparaty-iz-perechnya-zhnvlp-vyrosli-na-13-s-nachala-goda.html</loc></url><url><loc>https://market-access-solutions.ru/news/2094-v-sovfede-predlagayut-otmenit-prioritet-ceny-nad-kachestvom-pri-goszakupkah-v-socialnoy-sfere.html</loc></url><url><loc>https://market-access-solutions.ru/news/2095-fas-poyasnyaet-kak-formirovat-otpusknye-ceny-na-preparaty-iz-perechnya-zhnvlp.html</loc></url><url><loc>https://market-access-solutions.ru/news/2098-kompanii-uchrediteli-kotoryh-zaregistrirovany-v-ofshornyh-zonah-ne-smogut-uchastvovat-v-goszakupkah.html</loc></url><url><loc>https://market-access-solutions.ru/news/2100-s-2013-goda-v-proekty-sozdaniya-rossiyskih-lekarstv-bylo-vlozheno-okolo-89-mlrd-rubley.html</loc></url><url><loc>https://market-access-solutions.ru/news/2101-kommercheskiy-rynok-lekarstv-v-yanvare-iyune-2018-goda-vyros-po-sravneniyu-s-proshlym-godom.html</loc></url><url><loc>https://market-access-solutions.ru/news/2104-liderom-po-obemu-prodazh-do-2024-goda-budet-preparat-humira.html</loc></url><url><loc>https://market-access-solutions.ru/news/2105-v-rossii-mogut-vvesti-otvetstvennost-za-dachu-zavedomo-lozhnyh-zaklyucheniy-pri-goszakupkah.html</loc></url><url><loc>https://market-access-solutions.ru/news/211-isklyuchenie-bolshinstva-medizdeliy-iz-standartov-lecheniya-sozdast-slozhnosti-pri-okazanii-medpomoschi.html</loc></url><url><loc>https://market-access-solutions.ru/news/2116-ekspert-farma-2030-odnoznachno-vyglyadit-bolee-konkretnym-dokumentom.html</loc></url><url><loc>https://market-access-solutions.ru/news/212-fas-podderzhivaet-ideyu-prodazhi-lekarstv-v-torgovyh-setyah.html</loc></url><url><loc>https://market-access-solutions.ru/news/2122-ob-osobennostyah-opisaniya-medicinskih-izdeliy-yavlyayuschihsya-obektom-goszakupok.html</loc></url><url><loc>https://market-access-solutions.ru/news/2134-pravitelstvo-menyaet-pravila-lekobespecheniya-po-programme-vysokozatratnyh-nozologiy.html</loc></url><url><loc>https://market-access-solutions.ru/news/2135-kommercheskiy-rynok-lekarstvennyh-sredstv-za-sem-mesyacev-2018-goda-uvelichilsya-v-rublevom-ekvivalente-na-38-otnositelno-analogichnogo-perioda-prishlogo-goda.html</loc></url><url><loc>https://market-access-solutions.ru/news/2136-rossiya-budet-zakupat-innovacionnye-lekarstva-po-trehletnim-kontraktam.html</loc></url><url><loc>https://market-access-solutions.ru/news/2137-ceny-na-lekarstva-v-avguste-2018-goda-vyrosli-na-03.html</loc></url><url><loc>https://market-access-solutions.ru/news/2138-zavershena-konferenciya-ocenka-tehnologiy-zdravoohraneniya-povyshenie-effektivnosti-raboty-medicinskih-organizaciy.html</loc></url><url><loc>https://market-access-solutions.ru/news/2139-zakupochnye-ceny-na-zhnvlp-ambulatornogo-i-gospitalnogo-segmenta-v-avguste-2018-goda-ne-izmenilis-po-sravneniyu-s-proshlym-mesyacem.html</loc></url><url><loc>https://market-access-solutions.ru/news/2140-rnc-pharma-naturalnyy-obem-rossiyskogo-farmproizvodstva-sokraschaetsya-10-y-mesyac-podryad.html</loc></url><url><loc>https://market-access-solutions.ru/news/2141-iii-specializirovannaya-vystavka-medicina-2018.html</loc></url><url><loc>https://market-access-solutions.ru/news/2142-cherez-pyat-let-obem-eksporta-lekarstvennyh-sredstv-mozhet-dostignut-3-4-mlrd-dollarov-v-god.html</loc></url><url><loc>https://market-access-solutions.ru/news/2143-ekspert-finansovye-riski-v-ramkah-personalizirovannoy-pomoschi-nuzhno-razdelit-mezhdu-farmproizvoditelyami-i-gosudarstvom.html</loc></url><url><loc>https://market-access-solutions.ru/news/2146-reglament-eu-536-2014-o-klinicheskih-issledovaniyah-lekarstvennyh-preparatov-dlya-medicinskogo-primeneniya-evropeyskogo-soyuza-vstupaet-v-silu-v-2019-g.html</loc></url><url><loc>https://market-access-solutions.ru/news/2147-v-nii-zdravoohraneniya-oprovergli-sokraschenie-zatrat-na-lekarstva-lgotnikam.html</loc></url><url><loc>https://market-access-solutions.ru/news/2148-srok-vyvoda-na-rynok-vosproizvedennyh-lekarstv-mozhet-byt-sokraschen.html</loc></url><url><loc>https://market-access-solutions.ru/news/2149-rnc-pharma-za-yanvar-iyul-2018-g-import-gotovyh-lp-v-nashu-stranu-sostavil-2913-mlrd-rub.html</loc></url><url><loc>https://market-access-solutions.ru/news/2150-farma-2030-dolzhna-otrazhat-buduschie-izmeneniya-lekarstvennyh-i-medtehnologiy.html</loc></url><url><loc>https://market-access-solutions.ru/news/2151-po-itogam-i-polugodiya-zakupki-lekarstv-po-programme-lgotnogo-lekobespecheniya-sokratilis.html</loc></url><url><loc>https://market-access-solutions.ru/news/2152-rossiya-zanimaet-odno-iz-pervyh-mest-v-mire-po-kolichestvu-registriruemyh-preparatov-bioanalogov.html</loc></url><url><loc>https://market-access-solutions.ru/news/2154-model-zakupok-lekarstv-zavisit-ot-sistemy-lekarstvennogo-obespecheniya-v-celom.html</loc></url><url><loc>https://market-access-solutions.ru/news/2158-pravovye-instrumenty-zaschity-intellektualnoy-sobstvennosti-v-farmacevtike-v-evrosoyuze.html</loc></url><url><loc>https://market-access-solutions.ru/news/216-farmrynok-rf-v-2012-godu-sdelki-iniciativy-i-izmeneniya.html</loc></url><url><loc>https://market-access-solutions.ru/news/2160-pravitelstvo-uvelichilo-obem-subvenciy-regionam-na-lekarstvennoe-obespechenie-lgotnyh-kategoriy-naseleniya.html</loc></url><url><loc>https://market-access-solutions.ru/news/2168-razrabotany-izmeneniya-v-fz-v-chasti-regulirovaniya-cen-na-preparaty-iz-perechnya-zhnvlp.html</loc></url><url><loc>https://market-access-solutions.ru/news/2170-v-rf-sovershenstvuyutsya-procedury-gosregistracii-predelnyh-otpusknyh-cen-proizvoditeley-zhnvlp.html</loc></url><url><loc>https://market-access-solutions.ru/news/2172-rossiyskiy-farmacevticheskiy-rynok-segodnya-novye-instrumenty-dlya-biznesa-i-zdorove-nacii.html</loc></url><url><loc>https://market-access-solutions.ru/news/2173-zabolevaniya-organov-dyhaniya-zanimayut-trete-mesto-v-obschey-strukture-smertnosti.html</loc></url><url><loc>https://market-access-solutions.ru/news/2174-parallelnyy-import-lekarstv-i-medizdeliy-mozhet-nachatsya-uzhe-v-2021-godu.html</loc></url><url><loc>https://market-access-solutions.ru/news/2175-pereveden-na-russkiy-yazyk-zakon-o-regulirovanii-obrascheniya-lekarstv-v-es.html</loc></url><url><loc>https://market-access-solutions.ru/news/2177-minzdrav-opredelil-sluchai-obyazatelnogo-snizheniya-cen-na-zhnvlp.html</loc></url><url><loc>https://market-access-solutions.ru/news/2178-ekspert-net-faktorov-kotorye-by-rezko-vzorvali-rynok-na-potreblenie-farmrynok.html</loc></url><url><loc>https://market-access-solutions.ru/news/2179-minzdrav-opredelil-sluchai-obyazatelnogo-snizheniya-cen-na-zhnvlp.html</loc></url><url><loc>https://market-access-solutions.ru/news/2180-ekspert-to-chto-my-seychas-nablyudaem-samye-sereznye-izmeneniya-v-sisteme-cenoobrazovaniya.html</loc></url><url><loc>https://market-access-solutions.ru/news/2181-neobosnovanno-zhestkaya-regulyatorika-i-cenovoe-davlenie-privodit-k-nehvatke-neobhodimyh-lp.html</loc></url><url><loc>https://market-access-solutions.ru/news/2182-izmeneny-pravila-formirovaniya-perechney-lekarstvennyh-preparatov.html</loc></url><url><loc>https://market-access-solutions.ru/news/2190-v-federalnyy-zakon-budut-vneseny-izmeneniya-po-regulirovaniyu-cen-na-zhiznenno-neobhodimye-i-vazhneyshie-lekarstvennye-preparaty.html</loc></url><url><loc>https://market-access-solutions.ru/news/2195-voennye-anesteziologi-reanimatologi-sodeystvuyut-vnedreniyu-novyh-tehnologiy-v-praktiku-vrachey-silovyh-vedomstv.html</loc></url><url><loc>https://market-access-solutions.ru/news/2196-ekspert-novoe-cenoobrazovanie-mozhet-ubit-farmrynok.html</loc></url><url><loc>https://market-access-solutions.ru/news/2198-minzdrav-rossii-podgotovil-proekt-postanovleniya-pravitelstva-rossiyskoy-federacii.html</loc></url><url><loc>https://market-access-solutions.ru/news/2199-priem-vysokih-doz-sildenafila-dlya-lecheniya-erektilnoy-disfunkcii-mozhet-privesti-k-povrezhdeniyu-setchatki.html</loc></url><url><loc>https://market-access-solutions.ru/news/22-v-zakon-o-goszakupkah-vneseny-izmeneniya-obespechivayuschie-glasnost-i-prozrachnost-razmescheniya-zakazov.html</loc></url><url><loc>https://market-access-solutions.ru/news/2200-utverzhdena-programma-gosgarantiy-besplatnogo-okazaniya-grazhdanam-medpomoschi-na-2019-god.html</loc></url><url><loc>https://market-access-solutions.ru/news/2201-pozdravlyaem-s-nastupayuschim-novym-godom-i-rozhdestvom.html</loc></url><url><loc>https://market-access-solutions.ru/news/2202-rnc-pharma-v-noyabre-2018-g-postavki-gotovyh-lp-v-rossiyu-sokraschalis-kak-v-denezhnom-tak-i-v-naturalnom-vyrazhenii.html</loc></url><url><loc>https://market-access-solutions.ru/news/2203-farmacevticheskiy-forum-stran-eaes-i-sng.html</loc></url><url><loc>https://market-access-solutions.ru/news/2204-rnc-pharma-prirost-postavok-lp-iz-eaes-v-rossiyu-v-2018-g-suschestvenno-operezhal-srednerynochnuyu-dinamiku.html</loc></url><url><loc>https://market-access-solutions.ru/news/2205-rnc-pharma-v-2018-g-proizvodstvo-lp-v-rossii-pokazalo-hudshuyu-dinamiku-za-poslednie-4-goda.html</loc></url><url><loc>https://market-access-solutions.ru/news/2206-mirovye-rashody-na-preparaty-k-2023-godu-mogut-prevysit-15-trln-dollarov.html</loc></url><url><loc>https://market-access-solutions.ru/news/2207-v-2018-godu-bylo-odobreno-rekordnoe-kolichestvo-medizdeliy.html</loc></url><url><loc>https://market-access-solutions.ru/news/2208-obem-rossiyskogo-farmrynka-v-dekabre-2018-goda-sostavil-93-mlrd-rubley.html</loc></url><url><loc>https://market-access-solutions.ru/news/2209-rnc-pharma-import-gotovyh-lp-v-rossiyu-v-2018-g-sokratilsya-na-77-v-upakovkah.html</loc></url><url><loc>https://market-access-solutions.ru/news/2211-rnc-pharma-po-itogam-2018-g-lek-preparaty-stali-edinstvennoy-kategoriey-vet-produkcii-pokazavshey-rost-kak-naturalnyh-tak-i-denezhnyh-obemov-importa.html</loc></url><url><loc>https://market-access-solutions.ru/news/2212-ocenka-lekarstvennyh-sredstv-dlya-vklyucheniya-v-ogranichitelnye-perechni.html</loc></url><url><loc>https://market-access-solutions.ru/news/2213-kruglye-stoly-konferencii-klinicheskie-issledovaniya-v-eaes.html</loc></url><url><loc>https://market-access-solutions.ru/news/2214-rynok-kardiostimulyatorov-k-2028-godu-mozhet-sostavit-41-mlrd-dollarov-ssha.html</loc></url><url><loc>https://market-access-solutions.ru/news/2216-rossiyskiy-eksport-lekarstv-v-2018-godu-uvelichilsya-na-prakticheski-na-20-v-stoimostnom-vyrazhenii.html</loc></url><url><loc>https://market-access-solutions.ru/news/2217-ii-vserossiyskaya-konferenciya-intellektualnaya-sobstvennost-na-farmacevticheskom-rynke-ohrana-zaschita-prav-i-sudebnaya-praktika-2019-vesna.html</loc></url><url><loc>https://market-access-solutions.ru/news/2218-iii-vserossiyskaya-konferenciya-medicinskie-uchrezhdeniya-i-organizacii-pravovoe-regulirovanie-2019-vesna.html</loc></url><url><loc>https://market-access-solutions.ru/news/222-sessiya-ramn-predlozhila-strategiyu-razvitiya-medicinskoy-nauki-v-rossii.html</loc></url><url><loc>https://market-access-solutions.ru/news/2220-konferenciya-klinicheskie-issledovaniya-v-eaes-proydet-6-7-iyunya-v-sankt-peterburge.html</loc></url><url><loc>https://market-access-solutions.ru/news/2221-v-marte-rost-cen-na-lekarstva-sostavil-05.html</loc></url><url><loc>https://market-access-solutions.ru/news/2223-pobeditel-nominacii-naruzhnoe-sredstvo-dlya-zazhivleniya-rubcov-smartpharma-awards-2019.html</loc></url><url><loc>https://market-access-solutions.ru/news/2225-nominaciya-gel-pri-bolyah-v-spine-s-protivovospalitelnym-effektom-smartpharma-awards-2019.html</loc></url><url><loc>https://market-access-solutions.ru/news/2226-nominaciya-topicheskoe-sredstvo-dlya-profilaktiki-i-lecheniya-prostudy-na-gubah-smartpharma-awards-2019.html</loc></url><url><loc>https://market-access-solutions.ru/news/2227-nominaciya-luchshiy-vitaminnyy-kompleks-pri-saharnom-diabete-smartpharma-awards-2019.html</loc></url><url><loc>https://market-access-solutions.ru/news/2228-itogi-pervyh-dvuh-dney-2-ya-nacionalnaya-premiya-smartpharma-awards-2019.html</loc></url><url><loc>https://market-access-solutions.ru/news/223-minzdrav-provedet-reviziyu-dlya-vyvoda-s-rynka-neeffektivnyh-lekarstv.html</loc></url><url><loc>https://market-access-solutions.ru/news/2230-itogi-tretego-dnya-2-nacionalnoy-farmacevticheskoy-premii-smartpharma-awards.html</loc></url><url><loc>https://market-access-solutions.ru/news/2232-chetvertyy-den-2-y-nacionalnoy-farmacevticheskoy-premii-smartpharma-awards.html</loc></url><url><loc>https://market-access-solutions.ru/news/2233-itogi-2-y-nacionalnoy-farmacevticheskoy-premii-smartpharma-awards.html</loc></url><url><loc>https://market-access-solutions.ru/news/224-rossiya-reklama-lekarstvennyh-preparatov-v-specializirovannyh-pechatnyh-izdaniyah.html</loc></url><url><loc>https://market-access-solutions.ru/news/2246-v-iyule-nablyudalsya-znachitelnyy-rost-proizvodstva-otechestvennyh-preparatov.html</loc></url><url><loc>https://market-access-solutions.ru/news/225-dlo-rf-itogi-pervyh-9-mesyacev-2012-g.html</loc></url><url><loc>https://market-access-solutions.ru/news/2253-vklyuchenie-lekarstvennyh-preparatov-v-ogranichitelnye-perechni-poshagovyy-algoritm.html</loc></url><url><loc>https://market-access-solutions.ru/news/2256-v-2019-godu-rossiyskie-apteki-realizovali-lekarstvennyh-sredstv-na-summu-1021-trln-rubley.html</loc></url><url><loc>https://market-access-solutions.ru/news/2257-gryaduschie-izmeneniya-v-lgotnom-lekarstvennom-obespechenii-perechnya-onls-ne-budet-a-vmesto-nego-edinyy-dlya-regionov-perechen-zhnvlp.html</loc></url><url><loc>https://market-access-solutions.ru/news/2258-v-rossii-sozdadut-federalnyy-registr-lgotnikov.html</loc></url><url><loc>https://market-access-solutions.ru/news/2259-v-gosdumu-vnesli-zakonoproekt-napravlennyy-na-sovershenstvovanie-sistemy-lekobespecheniya.html</loc></url><url><loc>https://market-access-solutions.ru/news/226-olga-golodec-programma-modernizacii-zdravoohraneniya-budet-vypolnena-na-98.html</loc></url><url><loc>https://market-access-solutions.ru/news/2260-bolshe-tabletok-v-schitanye-ruki.html</loc></url><url><loc>https://market-access-solutions.ru/news/2261-dany-razyasneniya-po-zapolneniyu-formy-protokola-soglasovaniya-cen-postavki-zhnvlp.html</loc></url><url><loc>https://market-access-solutions.ru/news/2262-pravitelstvo-rf-namereno-uprostit-poryadok-zakupki-onkopreparatov-po-tn.html</loc></url><url><loc>https://market-access-solutions.ru/news/2263-zakon-o-federalnom-registre-lgotnikov-gosduma-rassmotrit-v-aprele.html</loc></url><url><loc>https://market-access-solutions.ru/news/2265-bolshe-tabletok-v-schitanye-ruki.html</loc></url><url><loc>https://market-access-solutions.ru/news/2266-roszdravnadzor-budet-monitorit-obem-zhiznenno-neobhodimyh-lekarstv-nahodyaschihsya-v-obraschenii.html</loc></url><url><loc>https://market-access-solutions.ru/news/227-57-zakonodatelnyh-aktov-privodyatsya-v-sootvetstvie-s-fz-ob-osnovah-ohrany-zdorovya-grazhdan-v-rf.html</loc></url><url><loc>https://market-access-solutions.ru/news/228-obem-rossiyskogo-farmrynka-po-itogam-2012-g-sostavit-poryadka-800-mlrd-rubley.html</loc></url><url><loc>https://market-access-solutions.ru/news/229-veronika-skvorcova-rasskazala-o-peremenah-v-zdravoohranenii-v-blizhayshie-sem-let.html</loc></url><url><loc>https://market-access-solutions.ru/news/231-v-2013-godu-vse-neobhodimye-vidy-medpomoschi-budut-okazyvatsya-v-gosudarstvennyh-i-municipalnyh-uchrezhdeniyah-besplatno.html</loc></url><url><loc>https://market-access-solutions.ru/news/232-utverzhdena-gosprogramma-razvitiya-zdravoohraneniya-rossii.html</loc></url><url><loc>https://market-access-solutions.ru/news/233-medvedev-neobhodimo-vyravnyat-obespechennost-regionov-lekarstvami.html</loc></url><url><loc>https://market-access-solutions.ru/news/234-v-kaluzhskoy-oblasti-lekarstvennoe-obespechenie-mogut-perevesti-na-differencirovannyy-princip.html</loc></url><url><loc>https://market-access-solutions.ru/news/235-farmrynok-smotrit-v-buduschee-s-optimizmom.html</loc></url><url><loc>https://market-access-solutions.ru/news/236-pravitelstvo-ogranichit-deyatelnost-farmkompaniy-po-lobbirovaniyu-svoey-produkcii.html</loc></url><url><loc>https://market-access-solutions.ru/news/240-associaciya-rossiyskih-farmacevticheskih-proizvoditeley-predlagaet-izbavitsya-ot-formirovaniya-spiska-zhiznenno-neobhodimyh-i-vazhneyshih-lekarstvennyh-sredstv.html</loc></url><url><loc>https://market-access-solutions.ru/news/241-v-gd-obsuzhdalsya-vopros-aktualnosti-vnedreniya-struktury-po-ocenke-medtehnologiy.html</loc></url><url><loc>https://market-access-solutions.ru/news/242-chtoby-stimulirovat-otechestvennoe-proizvodstvo-pravitelstvo-namereno-ogranichit-goszakupki-importnyh-lekarstv.html</loc></url><url><loc>https://market-access-solutions.ru/news/243-pravitelstvo-raspredelilo-subvencii-regionam-na-lgotnoe-lekarstvennoe-obespechenie.html</loc></url><url><loc>https://market-access-solutions.ru/news/244-regiony-poluchat-subsidii-na-organizaciyu-lekarstvennogo-obespecheniya-grazhdan-po-programme-7-nozologiy.html</loc></url><url><loc>https://market-access-solutions.ru/news/247-pravitelstvo-raspredelilo-subsidii-na-profilaktiku-i-lechenie-tuberkuleza.html</loc></url><url><loc>https://market-access-solutions.ru/news/248-senatory-odobrili-uvelichenie-finansirovaniya-lekarstvennogo-obespecheniya-lgotnikov-v-2013-g.html</loc></url><url><loc>https://market-access-solutions.ru/news/249-odobrena-strategiya-lekarstvennogo-obespecheniya-naseleniya-rf-do-2025-g.html</loc></url><url><loc>https://market-access-solutions.ru/news/25-licenzirovaniya-medicinskoy-i-farmacevticheskoy-deyatelnosti-sohranitsya.html</loc></url><url><loc>https://market-access-solutions.ru/news/250-chego-zhdut-vrachi-ot-medpredstaviteley.html</loc></url><url><loc>https://market-access-solutions.ru/news/251-pravitelstvo-rf-zaymetsya-snizheniem-cen-na-lekarstvennye-preparaty.html</loc></url><url><loc>https://market-access-solutions.ru/news/255-zhiteli-podmoskovya-v-srednem-tratyat-na-ls-9314-doll.html</loc></url><url><loc>https://market-access-solutions.ru/news/257-fas-predlozhila-registrirovat-bady-i-lekarstvennye-preparaty-po-odnoy-procedure.html</loc></url><url><loc>https://market-access-solutions.ru/news/260-minzdrav-rf-vnosit-popravki-v-fz-ob-obraschenii-lekarstvennyh-sredstv-i-nalogovyy-kodeks.html</loc></url><url><loc>https://market-access-solutions.ru/news/262-opravdanno-li-bylo-razdelenie-minzdravsocrazvitiya-na-minzdrav-i-mintrud.html</loc></url><url><loc>https://market-access-solutions.ru/news/264-ot-etapa-k-etapu.html</loc></url><url><loc>https://market-access-solutions.ru/news/268-biomedicinskaya-ekspertiza.html</loc></url><url><loc>https://market-access-solutions.ru/news/270-proekt-pravila-organizacii-proizvodstva-i-kontrolya-kachestva-lekarstvennyh-sredstv.html</loc></url><url><loc>https://market-access-solutions.ru/news/28-cherez-pyat-let-nasha-medicina-umret.html</loc></url><url><loc>https://market-access-solutions.ru/news/286-o-poryadke-utverzhdeniya-perechnya-lekarstvennyh-sredstv-razmeschenie-zakaza-na-postavku-kotoryh-dlya-nuzhd-zakazchikov-osuschestvlyaetsya-v-sootvetstvii-s-ih-torgovymi-naimenovaniyami.html</loc></url><url><loc>https://market-access-solutions.ru/news/300-perechen-preparatov-sem-nozologiy-budet-rasshiren.html</loc></url><url><loc>https://market-access-solutions.ru/news/304-popravki-k-fz-ob-obraschenii-lekarstvennyh-sredstv-mogut-uvelichit-zatraty-na-priobretenie-preparatov.html</loc></url><url><loc>https://market-access-solutions.ru/news/308-opredeleno-predelnoe-znachenie-nachalnoy-ceny-kontrakta-na-postavku-lekarstvennyh-preparatov.html</loc></url><url><loc>https://market-access-solutions.ru/news/324-minpromtorg-opredelil-kriterii-otneseniya-preparatov-k-lekarstvennym-sredstvam-rossiyskogo-proishozhdeniya.html</loc></url><url><loc>https://market-access-solutions.ru/news/330-sergey-kolesnikov-minzdrav-potoropilsya-s-vvedeniem-vypiski-receptov-po-mnn.html</loc></url><url><loc>https://market-access-solutions.ru/news/332-obem-kommercheskogo-rynka-gls-po-itogam-2012-g-sostavil-4051-mlrd-rub.html</loc></url><url><loc>https://market-access-solutions.ru/news/335-novovvedeniya-dolzhny-izbavit-rynok-ot-bespoleznyh-i-nekachestvennyh-preparatov.html</loc></url><url><loc>https://market-access-solutions.ru/news/337-k-2020-godu-rossiya-potratit-na-zdravoohranenie-27-trillionov.html</loc></url><url><loc>https://market-access-solutions.ru/news/338-rynok-vakcinacii-v-rossii-ezhegodno-rastet-na-20-v-god-po-sravneniyu-s-farmacevticheskim-eto-vyshe-na-8.html</loc></url><url><loc>https://market-access-solutions.ru/news/339-v-rossii-ozhidayut-povysheniya-cen-na-lekarstva.html</loc></url><url><loc>https://market-access-solutions.ru/news/340-falsifikaty-eto-razdutaya-piar-kompaniya-smi.html</loc></url><url><loc>https://market-access-solutions.ru/news/341-konkurenciya-na-rynke-lekarstv-mozhet-byt-suschestvenno-ogranichena.html</loc></url><url><loc>https://market-access-solutions.ru/news/344-eksperty-predlagayut-provodit-nezavisimye-klinicheskie-issledovaniya-sopostavlyayuschie-effektivnost-novyh-preparatov.html</loc></url><url><loc>https://market-access-solutions.ru/news/345-metodika-ustanovleniya-predelnyh-otpusknyh-cen-na-medikamenty-mozhet-byt-peresmotrena.html</loc></url><url><loc>https://market-access-solutions.ru/news/346-5-fevralya-pravitelstvo-rf-vneslo-v-gosdumu-zakonoproekt-217151-6-o-vnesenii-izmeneniy-v-otdelnye-zakonodatelnye-akty-rossiyskoy-federacii-v-svyazi-s-prinyatiem-federalnogo-zakona-ob-osnovah-ohrany.html</loc></url><url><loc>https://market-access-solutions.ru/news/347-ema-provodit-obschestvennuyu-konsultaciyu-kasayuschuyusya-direktivy-po-issledovaniyam-bioanalogov.html</loc></url><url><loc>https://market-access-solutions.ru/news/35-kto-zaplatit-za-reanimaciyu.html</loc></url><url><loc>https://market-access-solutions.ru/news/351-s-2014-goda-obespecheniem-lekarstvennymi-sredstvami-po-programme-sem-nozologiy-budut-zanimatsya-regiony.html</loc></url><url><loc>https://market-access-solutions.ru/news/352-spory-vokrug-popravok-v-fz-ob-obraschenii-lekarstvennyh-sredstv.html</loc></url><url><loc>https://market-access-solutions.ru/news/365-rossiyskie-proizvoditeli-zhdut-utverzhdeniya-prikaza-minekonomrazvitiya-o-preferenciyah.html</loc></url><url><loc>https://market-access-solutions.ru/news/371-minzdrav-utverdil-strategiyu-lekarstvennogo-obespecheniya-naseleniya-rossii-do-2025-goda.html</loc></url><url><loc>https://market-access-solutions.ru/news/382-minzdrav-rossii-zapuskaet-servis-vzaimodeystvie-lekarstvennyh-sredstv.html</loc></url><url><loc>https://market-access-solutions.ru/news/388-fas-za-otmenu-povtornyh-klinicheskih-issledovaniy-preparatov-inostrannogo-proizvodstva.html</loc></url><url><loc>https://market-access-solutions.ru/news/390-evrosoyuz-napravit-144-milliona-evro-na-issledovaniya-redkih-zabolevaniy.html</loc></url><url><loc>https://market-access-solutions.ru/news/391-ekspert-rossiyskie-lekarstva-vytesnyayut-import.html</loc></url><url><loc>https://market-access-solutions.ru/news/400-minzdrav-usovershenstvoval-regulirovanie-cen-na-preparaty-iz-perechnya-zhnvlp.html</loc></url><url><loc>https://market-access-solutions.ru/news/413-pravitelstvo-ne-podderzhalo-zakonoproekt-ob-izmenenii-poryadka-goszakupki-lekarstv.html</loc></url><url><loc>https://market-access-solutions.ru/news/420-vysokie-ceny-boyatsya-konkurencii.html</loc></url><url><loc>https://market-access-solutions.ru/news/431-arfp-minzdrav-uslyshal-predlozheniya-farmproizvoditeley-po-izmeneniyu-poryadka-registracii-cen.html</loc></url><url><loc>https://market-access-solutions.ru/news/432-organizaciya-sistemy-monitoringa-bezopasnosti-zaregistrirovannyh-medicinskih-izdeliy-v-rossiyskoy-federacii.html</loc></url><url><loc>https://market-access-solutions.ru/news/444-rossiya-ne-uspeet-pereyti-na-standarty-gmp-schitayut-eksperty.html</loc></url><url><loc>https://market-access-solutions.ru/news/447-pravitelstvo-utverdilo-predelnuyu-cenu-lota-pri-zakupke-lekarstv.html</loc></url><url><loc>https://market-access-solutions.ru/news/448-v-2012-g-na-lekarstvennoe-obespechenie-grazhdan-potracheno-okolo-320-mlrd-rubley.html</loc></url><url><loc>https://market-access-solutions.ru/news/449-associaciya-inpharma-ozvuchila-poziciyu-veduschih-innovacionnyh-farmkompaniy.html</loc></url><url><loc>https://market-access-solutions.ru/news/455-utverzhdeny-mery-po-obespecheniyu-sistemy-zdravoohraneniya-kadrami.html</loc></url><url><loc>https://market-access-solutions.ru/news/456-provoditsya-obschestvennaya-ekspertiza-pravil-organizacii-proizvodstva-i-kontrolya-kachestva-lekarstvennyh-sredstv.html</loc></url><url><loc>https://market-access-solutions.ru/news/457-v-techenie-pyati-let-deficit-ekonomicheski-gramotnyh-upravlencev-v-medicine-mozhet-byt-ustranen.html</loc></url><url><loc>https://market-access-solutions.ru/news/466-v-voprosah-podgotovki-standartov-ekspertizy-i-registracii-bioterapevticheskih-i-biopodobnyh-preparatov-rossiya-budet-sotrudnichat-s-voz.html</loc></url><url><loc>https://market-access-solutions.ru/news/468-golodec-poruchila-predstavit-novyy-scenariy-razvitiya-zdravoohraneniya.html</loc></url><url><loc>https://market-access-solutions.ru/news/472-preparaty-iz-perechnya-zhnvlp-vazhnye-i-dorogie.html</loc></url><url><loc>https://market-access-solutions.ru/news/473-reproduktivnoe-zdorove-rossiyan-v-zerkale-statistiki.html</loc></url><url><loc>https://market-access-solutions.ru/news/476-shest-celey-minzdrava-rf-na-blizhayshie-pyat-let.html</loc></url><url><loc>https://market-access-solutions.ru/news/49-monetizaciyu-lgot-ne-otmenyat.html</loc></url><url><loc>https://market-access-solutions.ru/news/491-raas-vnesla-predlozhenie-ob-otsrochke-pereregistracii-izdeliy-medicinskogo-naznacheniya.html</loc></url><url><loc>https://market-access-solutions.ru/news/498-4-ya-mezhdunarodnaya-specializirovannaya-vystavkakonferenciya-kompleksnogo-obespecheniya-farmacevticheskoy-promyshlennosti-pharmprom.html</loc></url><url><loc>https://market-access-solutions.ru/news/51-minzdrav-2013-god-budet-posvyaschen-sovershenstvovaniyu-zakonodatelstva.html</loc></url><url><loc>https://market-access-solutions.ru/news/52-spisok-lgotnikov-ne-sokratitsya.html</loc></url><url><loc>https://market-access-solutions.ru/news/520-predsedatel-komiteta-gosdumy-po-ohrane-zdorovya-sergey-kalashnikov.html</loc></url><url><loc>https://market-access-solutions.ru/news/522-prinyat-zakon-ob-ispolnenii-byudzheta-ffoms-na-2012-god.html</loc></url><url><loc>https://market-access-solutions.ru/news/523-osnovnaya-chast-sredstv-v-sleduyuschem-godu-budet-napravlena-minzdravom-na-redkie-bolezni-i-vysokotehnologichnuyu-medicinskuyu-pomosch.html</loc></url><url><loc>https://market-access-solutions.ru/news/54-minzdrav-rf-ne-isklyuchaet-vozmozhnosti-smyagcheniya-usloviy-otpuska-narkotikov-dlya-pacientov-s-hronicheskim-bolevym-sindromom.html</loc></url><url><loc>https://market-access-solutions.ru/news/547-viktor-dmitriev-v-usloviyah-sokrascheniya-byudzheta-vopros-racionalnogo-lekobespecheniya-obostryaetsya.html</loc></url><url><loc>https://market-access-solutions.ru/news/551-minzdrav-razrabotal-poryadok-formirovaniya-perechney-lekarstvennyh-preparatov.html</loc></url><url><loc>https://market-access-solutions.ru/news/560-ocenka-farmacevticheskogo-rynka-rossii-osen-2013.html</loc></url><url><loc>https://market-access-solutions.ru/news/566-zakupka-lekarstvennyh-sredstv-bez-provedeniya-torgov.html</loc></url><url><loc>https://market-access-solutions.ru/news/589-ministerstvo-zdravoohraneniya-rf-predlozhil-pomenyat-shemu-rascheta-cen-na-zhnvlp.html</loc></url><url><loc>https://market-access-solutions.ru/news/605-olgu-golodec-prosyat-vklyuchit-v-perechen-zhnvlp-sovremennye-ls-dlya-lecheniya-vich.html</loc></url><url><loc>https://market-access-solutions.ru/news/633-ozhidaetsya-deficit-preparatov-dlya-lecheniya-detey-s-onkologicheskimi-zabolevaniyami.html</loc></url><url><loc>https://market-access-solutions.ru/news/656-v-rossii-poyavilsya-gosudarstvennyy-institut-lekarstvennyh-sredstv-i-nadlezhaschih-praktik.html</loc></url><url><loc>https://market-access-solutions.ru/news/660-fas-rossii-gotovit-popravki-v-zakon-o-federalnoy-kontraktnoy-sisteme.html</loc></url><url><loc>https://market-access-solutions.ru/news/662-tehnicheskaya-dokumentaciya-na-medizdeliya-inostrannogo-proizvodstva-konsulskoy-legalizacii-ne-podlezhit.html</loc></url><url><loc>https://market-access-solutions.ru/news/670-deputaty-podderzhali-zakonoproekt-ob-otsrochke-ot-voennoy-sluzhby-dlya-obuchayuschihsya-v-internature-po-programmam-medicinskogo-i-farmacevticheskogo-obrazovaniya.html</loc></url><url><loc>https://market-access-solutions.ru/news/673-devalvaciya-protiv-pacientov.html</loc></url><url><loc>https://market-access-solutions.ru/news/681-pravitelstvo-rf-vneslo-v-gosdumu-zakonoproekt-s-izmeneniyami-v-zakonodatelstvo-v-chasti-obrascheniya-veterinarnyh-preparatov.html</loc></url><url><loc>https://market-access-solutions.ru/news/687-rynok-preparatov-dlya-lecheniya-hronicheskoy-bolezni-pochek-nachnet-rasti-posle-2017-goda.html</loc></url><url><loc>https://market-access-solutions.ru/news/688-sokraschenie-finansirovaniya-v-ssha-mozhet-skazatsya-na-razrabotke-novyh-preparatov-vo-vsem-mire.html</loc></url><url><loc>https://market-access-solutions.ru/news/691-analitiki-prognoziruyut-rost-mirovogo-rynka-biosimilyarov.html</loc></url><url><loc>https://market-access-solutions.ru/news/692-bolee-40-vzroslyh-zhiteley-rossii-stradayut-hronicheskimi-zabolevaniyami.html</loc></url><url><loc>https://market-access-solutions.ru/news/694-v-2013-godu-minzdrav-vydal-menshe-razresheniy-na-provedenie-klinicheskih-issledovaniy.html</loc></url><url><loc>https://market-access-solutions.ru/news/696-obem-rossiyskogo-farmrynka-prevysil-1-trillion-rubley.html</loc></url><url><loc>https://market-access-solutions.ru/news/699-utverzhdena-novaya-redakciya-gosprogrammy-razvitie-farmacevticheskoy-i-medicinskoy-promyshlennosti.html</loc></url><url><loc>https://market-access-solutions.ru/news/719-elena-maksimkina-vystupila-s-dokladom-na-mezhdunarodnoy-konferencii-kachestvo-lekarstvennyh-sredstv-i-medicinskih-izdeliy-sovremennye-trebovaniya-i-podhody.html</loc></url><url><loc>https://market-access-solutions.ru/news/720-pravitelstvo-rf-planiruet-k-2018-godu-obespechit-rossiyskiy-farmrynok-otechestvennymi-preparatami-na-90.html</loc></url><url><loc>https://market-access-solutions.ru/news/725-v-pravitelstvo-rf-napravlen-proekt-dokumenta-opredelyayuschego-kriterii-formirovaniya-perechney-lekarstv.html</loc></url><url><loc>https://market-access-solutions.ru/news/727-gosduma-prinyala-v-pervom-chtenii-zakonoproekt-s-izmeneniyami-v-zakonodatelstvo-v-chasti-obrascheniya-veterinarnyh-preparatov.html</loc></url><url><loc>https://market-access-solutions.ru/news/731-reviziya-imuschestva-neobhodimost-pereocenki-medicinskih-tehnologiy.html</loc></url><url><loc>https://market-access-solutions.ru/news/738-ivan-glushkov-chleny-evraziyskoy-ekonomicheskoy-komissii-dali-ponyat-chto-edinoy-registracii-lekarstv-v-eaes-ne-budet.html</loc></url><url><loc>https://market-access-solutions.ru/news/739-doklad-o-realizacii-programmy-gosudarstvennyh-garantiy-besplatnogo-okazaniya-grazhdanam-medicinskoy-pomoschi-v-2013-godu.html</loc></url><url><loc>https://market-access-solutions.ru/news/740-rukovoditel-fas-rossii-igor-artemev-predlozhil-proanalizirovat-farmacevticheskiy-sektor-na-predmet-horoshih-i-plohih-praktik-v-formate-briks.html</loc></url><url><loc>https://market-access-solutions.ru/news/741-prinyatie-popravok-k-zakonoproektu-o-protivodeystvii-oborotu-falsificirovannyh-lekarstv-i-biologicheski-aktivnyh-dobavok.html</loc></url><url><loc>https://market-access-solutions.ru/news/743-rosstat-otmechaet-rost-cen-na-lekarstvennye-preparaty-v-mae-2014-goda.html</loc></url><url><loc>https://market-access-solutions.ru/news/746-kruglyy-stol-patentnaya-zaschita-lekarstvennyh-sredstv.html</loc></url><url><loc>https://market-access-solutions.ru/news/753-elena-nevolina-nikakaya-regulyaciya-cen-na-zhnv-lp-seychas-ne-rabotaet.html</loc></url><url><loc>https://market-access-solutions.ru/news/755-otechestvennaya-medicinskaya-produkciya-zanimaet-lish-chetvert-rossiyskogo-rynka.html</loc></url><url><loc>https://market-access-solutions.ru/news/775-uglublenie-sankciy-mozhet-privesti-k-pereorientacii-importa-lekarstvennyh-preparatov.html</loc></url><url><loc>https://market-access-solutions.ru/news/787-k-2020-godu-obem-rynka-preparatov-dlya-lecheniya-sindroma-deficita-vnimaniya-s-giperaktivnostyu-dostignet-99-mlrd-dollarov-ssha.html</loc></url><url><loc>https://market-access-solutions.ru/news/798-itogi-sovmestnogo-zasedaniya-ekspertnyh-sovetov-po-razvitiyu-konkurencii-v-sfere-zdravoohraneniya.html</loc></url><url><loc>https://market-access-solutions.ru/news/802-roszdravnadzor-utverdil-poryadok-vedeniya-reestra-vydannyh-razresheniy-na-provedenie-klinicheskih-ispytaniy-medizdeliy.html</loc></url><url><loc>https://market-access-solutions.ru/news/825-rynok-ultrazvukovogo-oborudovaniya-v-blizhayshie-pyat-let-mozhet-uvelichitsya-na-27.html</loc></url><url><loc>https://market-access-solutions.ru/news/826-lokalizaciya-eto-upakovka-lekarstv-ili-ih-proizvodstvo.html</loc></url><url><loc>https://market-access-solutions.ru/news/827-metodicheskoe-obespechenie-registracii-lekarstvennyh-sredstv-analiz-mirovogo-opyta.html</loc></url><url><loc>https://market-access-solutions.ru/news/830-rossiyskaya-farmindustriya-hochet-zhit-po-novym-pravilam.html</loc></url><url><loc>https://market-access-solutions.ru/news/844-utverzhden-poryadok-formirovaniya-perechney-medizdeliy.html</loc></url><url><loc>https://market-access-solutions.ru/news/845-rossiyskie-farmacevticheskie-kompanii-doveryayut-cro-tolko-14-klinicheskih-issledovaniy.html</loc></url><url><loc>https://market-access-solutions.ru/news/849-eksperty-otechestvennoy-farmindustrii-podgotovili-prilozhenie-k-pervym-v-rossii-pravilam-po-issledovaniyu-bioanalogov.html</loc></url><url><loc>https://market-access-solutions.ru/news/851-gosduma-prinyala-v-pervom-chtenii-zakonoproekt-ob-uproschenii-processa-registracii-orfannyh-ls.html</loc></url><url><loc>https://market-access-solutions.ru/news/857-fas-predlagaet-ogranichit-vydachu-patentov-na-otkrytie-novogo-svoystva-i-primeneniya-uzhe-izvestnogo-veschestva.html</loc></url><url><loc>https://market-access-solutions.ru/news/860-direktor-departamenta-elena-maksimkina-v-intervyu-rossiyskoy-gazete-rasskazala-ob-izmeneniyah-v-zakonodatelstvo-v-sfere-obrascheniya-lekarstvennyh-sredstv-podgotovlennyh-minzdravom-rossii.html</loc></url><url><loc>https://market-access-solutions.ru/news/870-sistemu-sozdaniya-novyh-lekarstv-raskritikovali-na-forume-v-tomske.html</loc></url><url><loc>https://market-access-solutions.ru/news/873-sistemu-razdelili.html</loc></url><url><loc>https://market-access-solutions.ru/news/874-neobhodimost-unifikacii-evropa-na-puti-k-ocenke-orfannyh-medicinskih-tehnologiy.html</loc></url><url><loc>https://market-access-solutions.ru/news/888-bioprinting-segodnya-zavtra-poslezavtra.html</loc></url><url><loc>https://market-access-solutions.ru/news/892-cherez-dva-tri-goda-bolshinstvo-lekarstv-iz-spiska-zhnvlp-budut-proizvoditsya-v-rossii.html</loc></url><url><loc>https://market-access-solutions.ru/news/898-gosudarstvennaya-duma-rf-prinyala-v-pervom-chtenii-zakonoproekt-o-promyshlennoy-politike-rf.html</loc></url><url><loc>https://market-access-solutions.ru/news/901-rossiyskie-cro-priobretayut-otechestvennye-clinical-trial-management-systems.html</loc></url><url><loc>https://market-access-solutions.ru/news/917-podmoskove-vydelilo-6-milliardov-na-lekarstva-dlya-lgotnikov.html</loc></url><url><loc>https://market-access-solutions.ru/news/919-proektnyy-menedzhment-v-razrabotke-i-issledovanii-lekarstvennyh-sredstv.html</loc></url><url><loc>https://market-access-solutions.ru/news/922-proshedshie-dokumentalnuyu-ekspertizu-predlozheniya-dlya-vklyucheniya-isklyucheniya-v-perechni-i-minimalnyy-assortiment.html</loc></url><url><loc>https://market-access-solutions.ru/news/927-ceny-na-zhnvlp-inostrannye-kompanii-nahodyatsya-v-neravnyh-usloviyah-po-sravneniyu-s-rossiyskimi.html</loc></url><url><loc>https://market-access-solutions.ru/news/928-minpromtorg-vnosit-izmeneniya-v-postanovlenie-1186-ot-19122013-g.html</loc></url><url><loc>https://market-access-solutions.ru/news/933-ceny-na-lekarstva-v-rossii-mogut-strogo-ogranichit.html</loc></url><url><loc>https://market-access-solutions.ru/news/938-zarubezhnye-kompanii-sokraschayut-proizvodstvo-zhiznenno-neobhodimyh-lekarstv-iz-za-padeniya-kursa-rublya.html</loc></url><url><loc>https://market-access-solutions.ru/news/960-sergey-cyb-proekty-realizuemye-v-sankt-peterburge-flagmany-farmindustrii-rossii.html</loc></url><url><loc>https://market-access-solutions.ru/news/961-gosduma-vo-vtorom-chtenii-prinyala-popravki-k-zakonu-obraschenii-lekarstvennyh-sredstv.html</loc></url><url><loc>https://market-access-solutions.ru/news/967-sformirovana-komissiya-po-voprosam-podderzhki-importozamescheniya-promyshlennosti-v-rossii.html</loc></url><url><loc>https://market-access-solutions.ru/news/985-k-2020-godu-dolya-rossiyskih-lekarstvennyh-preparatov-na-vnutrennem-rynke-dolzhna-sostavit-50.html</loc></url><url><loc>https://market-access-solutions.ru/news/989-denis-manturov-otechestvennaya-farmotrasl-nahoditsya-na-etape-aktivnoy-modernizacii.html</loc></url><url><loc>https://market-access-solutions.ru/news/993-utverzhdena-programma-besplatnogo-okazaniya-medpomoschi-na-2015-god.html</loc></url><url><loc>https://market-access-solutions.ru/news/994-genprokuratura-organy-vlasti-vseh-urovney-narushayut-zakonodatelstvo-v-sfere-oborota-lekarstv.html</loc></url><url><loc>https://market-access-solutions.ru/news/page/10/</loc></url><url><loc>https://market-access-solutions.ru/news/page/106/</loc></url><url><loc>https://market-access-solutions.ru/news/page/11/</loc></url><url><loc>https://market-access-solutions.ru/news/page/12/</loc></url><url><loc>https://market-access-solutions.ru/news/page/13/</loc></url><url><loc>https://market-access-solutions.ru/news/page/173/</loc></url><url><loc>https://market-access-solutions.ru/news/page/2/</loc></url><url><loc>https://market-access-solutions.ru/news/page/3/</loc></url><url><loc>https://market-access-solutions.ru/news/page/4/</loc></url><url><loc>https://market-access-solutions.ru/news/page/5/</loc></url><url><loc>https://market-access-solutions.ru/news/page/6/</loc></url><url><loc>https://market-access-solutions.ru/news/page/7/</loc></url><url><loc>https://market-access-solutions.ru/news/page/8/</loc></url><url><loc>https://market-access-solutions.ru/news/page/9/</loc></url><url><loc>https://market-access-solutions.ru/partners</loc></url><url><loc>https://market-access-solutions.ru/partners/</loc></url><url><loc>https://market-access-solutions.ru/partners/357-nauchnyy-centr-serdechno-sosudistoy-hirurgii-im-a-n-bakuleva-ramn.html</loc></url><url><loc>https://market-access-solutions.ru/partners/358-kachestvennaya-klinicheskaya-praktika-zhurnal.html</loc></url><url><loc>https://market-access-solutions.ru/partners/359-farmakokinetika-i-farmakodinamika-zhurnal.html</loc></url><url><loc>https://market-access-solutions.ru/partners/360-klinicheskaya-farmaciya-zhurnal.html</loc></url><url><loc>https://market-access-solutions.ru/partners/361-izdatelstvo-oki.html</loc></url><url><loc>https://market-access-solutions.ru/partners/529-spravochno-pravovoy-portal-farmacevtika-i-pravo-yuridicheskoy-firmy-bras.html</loc></url><url><loc>https://market-access-solutions.ru/partners/549-ukrmedsert.html</loc></url><url><loc>https://market-access-solutions.ru/partners/718-professionalnaya-medicinskaya-associaciya-klinicheskih-farmakologov-sankt-peterburga-i-severo-zapadnogo-regiona.html</loc></url><url><loc>https://market-access-solutions.ru/partners/904-pervaya-v-rossii-studiya-medicinskoy-vizualizacii-nanobotmodelscom-poyavilas-v-moskve.html</loc></url><url><loc>https://market-access-solutions.ru/publications</loc></url><url><loc>https://market-access-solutions.ru/publications/</loc></url><url><loc>https://market-access-solutions.ru/publications/269-analiz-potrebleniya-statinov-v-rossii-v-2010-2011-godu.html</loc></url><url><loc>https://market-access-solutions.ru/publications/543-vyshlo-v-svet-metodicheskoe-posobie-osnovnye-ponyatiya-v-ocenke-medicinskih-tehnologiy-2013-g.html</loc></url><url><loc>https://market-access-solutions.ru/reference</loc></url><url><loc>https://market-access-solutions.ru/reference/</loc></url><url><loc>https://market-access-solutions.ru/reference/882-maksimkina-elena-anatolevna.html</loc></url><url><loc>https://market-access-solutions.ru/reference/journals</loc></url><url><loc>https://market-access-solutions.ru/reference/medicines</loc></url><url><loc>https://market-access-solutions.ru/reference/medicines/</loc></url><url><loc>https://market-access-solutions.ru/reference/medicines/313-perechen-zhiznenno-neobhodimyh-lekarstvennyh-sredstv-formulyarnogo-komiteta.html</loc></url><url><loc>https://market-access-solutions.ru/reference/medicines/314-perechen-lekarstvennyh-sredstv-dlya-okazaniya-medicinskoy-pomoschi-v-ambulatorno-poliklinicheskih-usloviyah-ambulatornyy-formulyar.html</loc></url><url><loc>https://market-access-solutions.ru/reference/medicines/315-perechen-lekarstvennyh-sredstv-dlya-okazaniya-medicinskoy-pomoschi-v-usloviyah-stacionara-stacionarnyy-formulyar.html</loc></url><url><loc>https://market-access-solutions.ru/reference/medicines/316-perechen-zhiznenno-neobhodimyh-lekarstvennyh-sredstv-dlya-pediatricheskoy-praktiki-pediatricheskiy-formulyar.html</loc></url><url><loc>https://market-access-solutions.ru/reference/medicines/317-perechen-redkih-medicinskih-tehnologiy-evrosoyuza.html</loc></url><url><loc>https://market-access-solutions.ru/reference/medicines/318-perechen-redko-primenyaemyh-medicinskih-tehnologiy-formulyarnogo-komiteta.html</loc></url><url><loc>https://market-access-solutions.ru/reference/medicines/319-negativnyy-perechen-medicinskih-tehnologiy-formulyarnogo-komiteta.html</loc></url><url><loc>https://market-access-solutions.ru/reference/medicines/772-dzheneriki-viagry.html</loc></url><url><loc>https://market-access-solutions.ru/reference/organization</loc></url><url><loc>https://market-access-solutions.ru/reference/organization/</loc></url><url><loc>https://market-access-solutions.ru/reference/organization/289-soyuz-professionalnyh-farmacevticheskih-organizaciy-spfo.html</loc></url><url><loc>https://market-access-solutions.ru/reference/person</loc></url><url><loc>https://market-access-solutions.ru/reference/person/</loc></url><url><loc>https://market-access-solutions.ru/reference/person/275-chazov-evgeniy-ivanovich.html</loc></url><url><loc>https://market-access-solutions.ru/reference/person/278-dmitriev-viktor-aleksandrovich.html</loc></url><url><loc>https://market-access-solutions.ru/reference/person/279-ignateva-nelli-valentinovna.html</loc></url><url><loc>https://market-access-solutions.ru/reference/person/294-artemev-igor-yurevich.html</loc></url><url><loc>https://market-access-solutions.ru/reference/person/56-belousov-yuriy-borisovich.html</loc></url><url><loc>https://market-access-solutions.ru/reference/person/58-zherdev-vladimir-pavlovich.html</loc></url><url><loc>https://market-access-solutions.ru/reference/person/907-liliya-titova-izbrana-ispolnitelnym-direktorom-soyuza-professionalnyh-farmacevticheskih-organizaciy.html</loc></url><url><loc>https://market-access-solutions.ru/reference/person/page/2</loc></url><url><loc>https://market-access-solutions.ru/reference/recommendations</loc></url><url><loc>https://market-access-solutions.ru/reference/standarts</loc></url><url><loc>https://market-access-solutions.ru/reference/standarts/</loc></url><url><loc>https://market-access-solutions.ru/reference/standarts/509-o-standartah-okazaniya-medicinskoy-pomoschi.html</loc></url><url><loc>https://market-access-solutions.ru/reference/terminology</loc></url><url><loc>https://market-access-solutions.ru/reference/terminology/</loc></url><url><loc>https://market-access-solutions.ru/reference/terminology/100-perekrestnoe-issledovanie.html</loc></url><url><loc>https://market-access-solutions.ru/reference/terminology/101-pilotnoe-issledovanie.html</loc></url><url><loc>https://market-access-solutions.ru/reference/terminology/102-placebo-kontroliruemoe-issledovanie.html</loc></url><url><loc>https://market-access-solutions.ru/reference/terminology/103-prospektivnoe-issledovanie.html</loc></url><url><loc>https://market-access-solutions.ru/reference/terminology/104-randomizirovannoe-issledovanie.html</loc></url><url><loc>https://market-access-solutions.ru/reference/terminology/106-sravnitelnoe-issledovanie.html</loc></url><url><loc>https://market-access-solutions.ru/reference/terminology/107-stratificirovannoe-issledovanie.html</loc></url><url><loc>https://market-access-solutions.ru/reference/terminology/109-shema-issledovaniya.html</loc></url><url><loc>https://market-access-solutions.ru/reference/terminology/110-issledovatel.html</loc></url><url><loc>https://market-access-solutions.ru/reference/terminology/111-kachestvennaya-klinicheskaya-praktika-kkp.html</loc></url><url><loc>https://market-access-solutions.ru/reference/terminology/112-kachestvennaya-peremennaya.html</loc></url><url><loc>https://market-access-solutions.ru/reference/terminology/113-klinicheskaya-znachimost.html</loc></url><url><loc>https://market-access-solutions.ru/reference/terminology/114-kontraktno-issledovatelskaya-organizaciya-kio.html</loc></url><url><loc>https://market-access-solutions.ru/reference/terminology/115-kriterii-vklyucheniya.html</loc></url><url><loc>https://market-access-solutions.ru/reference/terminology/116-kriterii-isklyucheniya.html</loc></url><url><loc>https://market-access-solutions.ru/reference/terminology/118-materialy-issledovaniya.html</loc></url><url><loc>https://market-access-solutions.ru/reference/terminology/120-monitor.html</loc></url><url><loc>https://market-access-solutions.ru/reference/terminology/122-moschnost-issledovaniya.html</loc></url><url><loc>https://market-access-solutions.ru/reference/terminology/124-narushenie-protokola.html</loc></url><url><loc>https://market-access-solutions.ru/reference/terminology/125-nezhelatelnaya-lekarstvennaya-reakciya.html</loc></url><url><loc>https://market-access-solutions.ru/reference/terminology/126-nezhelatelnoe-yavlenie.html</loc></url><url><loc>https://market-access-solutions.ru/reference/terminology/127-opornoe-issledovanie.html</loc></url><url><loc>https://market-access-solutions.ru/reference/terminology/128-otchet-o-menedzhmente-dannyh.html</loc></url><url><loc>https://market-access-solutions.ru/reference/terminology/145-perekrestnoe-issledovanie.html</loc></url><url><loc>https://market-access-solutions.ru/reference/terminology/151-placebo.html</loc></url><url><loc>https://market-access-solutions.ru/reference/terminology/152-postmarketingovoe-issledovanie-nablyudatelnoe-issledovanie.html</loc></url><url><loc>https://market-access-solutions.ru/reference/terminology/155-randomizacionnyy-kod.html</loc></url><url><loc>https://market-access-solutions.ru/reference/terminology/173-soissledovatel.html</loc></url><url><loc>https://market-access-solutions.ru/reference/terminology/175-statisticheskiy-analiz.html</loc></url><url><loc>https://market-access-solutions.ru/reference/terminology/176-stratifikaciya.html</loc></url><url><loc>https://market-access-solutions.ru/reference/terminology/177-cel-issledovaniya.html</loc></url><url><loc>https://market-access-solutions.ru/reference/terminology/198-hrqol.html</loc></url><url><loc>https://market-access-solutions.ru/reference/terminology/237-standart-gcp.html</loc></url><url><loc>https://market-access-solutions.ru/reference/terminology/238-standart-glp.html</loc></url><url><loc>https://market-access-solutions.ru/reference/terminology/65-analiz-statisticheskiy.html</loc></url><url><loc>https://market-access-solutions.ru/reference/terminology/68-bumazhnyy-sled.html</loc></url><url><loc>https://market-access-solutions.ru/reference/terminology/70-vvodnyy-period-issledovaniya.html</loc></url><url><loc>https://market-access-solutions.ru/reference/terminology/74-gruppa-sravneniya.html</loc></url><url><loc>https://market-access-solutions.ru/reference/terminology/83-elektronnyy-vvod-dannyh.html</loc></url><url><loc>https://market-access-solutions.ru/reference/terminology/84-dvoynoe-slepoe-zamaskirovannoe-issledovanie.html</loc></url><url><loc>https://market-access-solutions.ru/reference/terminology/87-dizayn-sootvetstvuyuschih-par.html</loc></url><url><loc>https://market-access-solutions.ru/reference/terminology/88-doklinicheskoe-issledovanie.html</loc></url><url><loc>https://market-access-solutions.ru/reference/terminology/91-zamaskirovannoe-slepoe-issledovanie.html</loc></url><url><loc>https://market-access-solutions.ru/reference/terminology/92-identifikacionnyy-kod-subekta-issledovaniya.html</loc></url><url><loc>https://market-access-solutions.ru/reference/terminology/93-identifikacionnyy-spisok-pacientov.html</loc></url><url><loc>https://market-access-solutions.ru/reference/terminology/94-individualnaya-registracionnaya-karta-irk.html</loc></url><url><loc>https://market-access-solutions.ru/reference/terminology/95-absolyutno-slepoe-issledovanie.html</loc></url><url><loc>https://market-access-solutions.ru/reference/terminology/96-issledovanie-bioekvivalentnosti.html</loc></url><url><loc>https://market-access-solutions.ru/reference/terminology/97-marketingovoe-issledovanie.html</loc></url><url><loc>https://market-access-solutions.ru/reference/terminology/99-otkrytoe-issledovanie.html</loc></url><url><loc>https://market-access-solutions.ru/references.html</loc></url><url><loc>https://market-access-solutions.ru/research/bioequivalence_studies</loc></url><url><loc>https://market-access-solutions.ru/research/clinical_trials</loc></url><url><loc>https://market-access-solutions.ru/research/non-interventional_studies</loc></url><url><loc>https://market-access-solutions.ru/research/pharmacoeconomics_study</loc></url><url><loc>https://market-access-solutions.ru/research/pharmacoepidemiological_research</loc></url><url><loc>https://market-access-solutions.ru/research/pharmacoepidemiological_research/378-farmakoepidemiologicheskoe-issledovanie-po-ocenke-udovletvorennosti-pacientov-lecheniem-saharnogo-diabeta-2-tipa-forsaytsd2.html</loc></url><url><loc>https://market-access-solutions.ru/research/therapeutic_equivalence_studies</loc></url><url><loc>https://market-access-solutions.ru/services</loc></url><url><loc>https://market-access-solutions.ru/services/</loc></url><url><loc>https://market-access-solutions.ru/services/health_technology_assessment</loc></url><url><loc>https://market-access-solutions.ru/services/health_technology_assessment/</loc></url><url><loc>https://market-access-solutions.ru/services/health_technology_assessment/189-ob-ocenke-medicinskih-tehnologiy-firmoy-market-access-solutions-mas.html</loc></url><url><loc>https://market-access-solutions.ru/services/market_access</loc></url><url><loc>https://market-access-solutions.ru/services/market_access/36-market-access.html</loc></url><url><loc>https://market-access-solutions.ru/services/market_access_assessment</loc></url><url><loc>https://market-access-solutions.ru/services/media_planning</loc></url><url><loc>https://market-access-solutions.ru/services/media_planning/</loc></url><url><loc>https://market-access-solutions.ru/services/media_planning/46-mediaplanirovanie.html</loc></url><url><loc>https://market-access-solutions.ru/services/optimization_strategy</loc></url><url><loc>https://market-access-solutions.ru/services/optimization_strategy/</loc></url><url><loc>https://market-access-solutions.ru/services/optimization_strategy/38-optimizaciya-strategii.html</loc></url><url><loc>https://market-access-solutions.ru/services/registration</loc></url><url><loc>https://market-access-solutions.ru/services/registration/</loc></url><url><loc>https://market-access-solutions.ru/services/registration/59-gosudarstvennaya-registraciya-lekarstvennyh-preparatov.html</loc></url><url><loc>https://market-access-solutions.ru/services/registration/60-registraciya-farmacevticheskih-substanciy.html</loc></url><url><loc>https://market-access-solutions.ru/services/registration/61-registraciya-izdeliy-medicinskogo-naznacheniya.html</loc></url><url><loc>https://market-access-solutions.ru/services/reimbersment</loc></url><url><loc>https://market-access-solutions.ru/services/reimbersment/</loc></url><url><loc>https://market-access-solutions.ru/services/reimbersment/37-reimbersment.html</loc></url><url><loc>https://market-access-solutions.ru/services/research_expenses</loc></url><url><loc>https://market-access-solutions.ru/services/research_expenses/</loc></url><url><loc>https://market-access-solutions.ru/services/research_expenses/41-issledovaniya-bioekvivalentnosti.html</loc></url><url><loc>https://market-access-solutions.ru/services/research_expenses/43-klinicheskie-issledovaniya.html</loc></url><url><loc>https://market-access-solutions.ru/services/research_expenses/44-neintervencionnye-nablyudatelnye.html</loc></url><url><loc>https://market-access-solutions.ru/services/research_expenses/45-farmakoekonomicheskie-issledovaniya.html</loc></url><url><loc>https://market-access-solutions.ru/statistics.html</loc></url><url><loc>https://market-access-solutions.ru/tags/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%90%D1%81%D1%81%D0%BE%D1%86%D0%B8%D0%B0%D1%86%D0%B8%D1%8F+%D0%BA%D0%BB%D0%B8%D0%BD%D0%B8%D1%87%D0%B5%D1%81%D0%BA%D0%B8%D1%85+%D1%84%D0%B0%D1%80%D0%BC%D0%B0%D0%BA%D0%BE%D0%BB%D0%BE%D0%B3%D0%BE%D0%B2</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%92%D0%BB%D0%B0%D0%B4%D0%B8%D0%BC%D0%B8%D1%80+%D0%9F%D1%83%D1%82%D0%B8%D0%BD/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%93%D0%BE%D1%81%D0%B4%D1%83%D0%BC%D0%B0+%D0%A0%D0%A4/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%93%D0%BE%D1%81%D0%B4%D1%83%D0%BC%D0%B0/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%94%D0%9B%D0%9E/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%94%D0%B5%D0%BF%D0%B0%D1%80%D1%82%D0%B0%D0%BC%D0%B5%D0%BD%D1%82+%D0%BB%D0%B5%D0%BA%D0%B0%D1%80%D1%81%D1%82%D0%B2%D0%B5%D0%BD%D0%BD%D0%BE%D0%B3%D0%BE+%D0%BE%D0%B1%D0%B5%D1%81%D0%BF%D0%B5%D1%87%D0%B5%D0%BD%D0%B8%D1%8F+%D0%B8+%D1%80%D0%B5%D0%B3%D1%83%D0%BB%D0%B8%D1%80%D0%BE%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F+%D0%BE%D0%B1%D1%80%D0%B0%D1%89%D0%B5%D0%BD%D0%B8%D1%8F+%D0%BC%D0%B5%D0%B4%D0%B8%D1%86%D0%B8%D0%BD%D1%81%D0%BA%D0%B8%D1%85+%D0%B8%D0%B7%D0%B4%D0%B5%D0%BB%D0%B8%D0%B9</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%94%D0%BC%D0%B8%D1%82%D1%80%D0%B8%D0%B9+%D0%9C%D0%B5%D0%B4%D0%B2%D0%B5%D0%B4%D0%B5%D0%B2/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%95%D0%90%D0%AD%D0%A1/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%95%D0%B2%D1%80%D0%B0%D0%B7%D0%B8%D0%B9%D1%81%D0%BA%D0%B8%D0%B9+%D1%8D%D0%BA%D0%BE%D0%BD%D0%BE%D0%BC%D0%B8%D1%87%D0%B5%D1%81%D0%BA%D0%B8%D0%B9+%D1%81%D0%BE%D1%8E%D0%B7/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%95%D0%BB%D0%B5%D0%BD%D0%B0%20%D0%9C%D0%B0%D0%BA%D1%81%D0%B8%D0%BC%D0%BA%D0%B8%D0%BD%D0%B0</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%95%D0%BB%D0%B5%D0%BD%D0%B0+%D0%9C%D0%B0%D0%BA%D1%81%D0%B8%D0%BC%D0%BA%D0%B8%D0%BD%D0%B0</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%96%D0%9D%D0%92%D0%9B%D0%9F/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%97%D0%B4%D0%BE%D1%80%D0%BE%D0%B2%D1%8C%D0%B5+%D0%A0%D0%BE%D1%81%D1%81%D0%B8%D0%B8/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%9A%D0%98%D0%9E/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%9C%D0%B0%D0%BA%D1%81%D0%B8%D0%BC%D0%BA%D0%B8%D0%BD%D0%B0+%D0%95%D0%BB%D0%B5%D0%BD%D0%B0</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%9C%D0%B5%D1%80%D0%BA/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%9C%D0%B8%D0%BD%D0%B7%D0%B4%D1%80%D0%B0%D0%B2+%D0%A0%D0%A4</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%9C%D0%B8%D0%BD%D0%B7%D0%B4%D1%80%D0%B0%D0%B2+%D0%A0%D0%A4/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%9C%D0%B8%D0%BD%D0%B7%D0%B4%D1%80%D0%B0%D0%B2/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%9C%D0%B8%D0%BD%D0%B8%D1%81%D1%82%D0%B5%D1%80%D1%81%D1%82%D0%B2%D0%BE+%D0%B7%D0%B4%D1%80%D0%B0%D0%B2%D0%BE%D0%BE%D1%85%D1%80%D0%B0%D0%BD%D0%B5%D0%BD%D0%B8%D1%8F+%D0%A0%D0%A4/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%9C%D0%B8%D0%BD%D0%BF%D1%80%D0%BE%D0%BC%D1%82%D0%BE%D1%80%D0%B3/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%9D%D0%B0%D1%86%D0%B8%D0%BE%D0%BD%D0%B0%D0%BB%D1%8C%D0%BD%D0%B0%D1%8F+%D0%90%D1%81%D1%81%D0%BE%D1%86%D0%B8%D0%B0%D1%86%D0%B8%D1%8F+%D0%BE%D1%80%D0%B3%D0%B0%D0%BD%D0%B8%D0%B7%D0%B0%D1%86%D0%B8%D0%B9+%D0%B1%D0%BE%D0%BB%D1%8C%D0%BD%D1%8B%D1%85+%D1%80%D0%B5%D0%B4%D0%BA%D0%B8%D0%BC%D0%B8+%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F%D0%BC%D0%B8+%C2%AB%D0%93%D0%B5%D0%BD%D0%B5%D1%82%D0%B8%D0%BA%D0%B0%C2%BB</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%9E%D0%9C%D0%A1/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%9E%D0%9C%D0%A2/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%9E%D0%9D%D0%9B%D0%A1/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%9F%D1%80%D0%B0%D0%B2%D0%B8%D1%82%D0%B5%D0%BB%D1%8C%D1%81%D1%82%D0%B2%D0%BE+%D0%A0%D0%A4/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%9F%D1%80%D0%B0%D0%B2%D0%B8%D1%82%D0%B5%D0%BB%D1%8C%D1%81%D1%82%D0%B2%D0%BE+%D0%A0%D0%A4/page/2/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%9F%D1%80%D0%B0%D0%B2%D0%B8%D1%82%D0%B5%D0%BB%D1%8C%D1%81%D1%82%D0%B2%D0%BE+%D0%A0%D0%A4/page/3/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%9F%D1%80%D0%B8%D0%BA%D0%B0%D0%B7+%E2%84%96529%D0%BD/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%A0%D0%BE%D1%81%D0%B7%D0%B4%D1%80%D0%B0%D0%B2%D0%BD%D0%B0%D0%B4%D0%B7%D0%BE%D1%80/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%A0%D0%BE%D1%81%D1%81%D0%B8%D1%8F/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%A1%D0%95%D0%90/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%A1%D0%9C%D0%90/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%A1%D0%9E%D0%A7%D0%98-%D0%AD%D0%9A%D0%A1%D0%9F%D0%9E/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%A1%D0%9F%D0%A4%D0%9E/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%A1%D0%B5%D1%80%D0%B3%D0%B5%D0%B9+%D0%A6%D1%8B%D0%B1/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%A1%D0%BA%D0%B2%D0%BE%D1%80%D1%86%D0%BE%D0%B2%D0%B0+%D0%92%D0%B5%D1%80%D0%BE%D0%BD%D0%B8%D0%BA%D0%B0+%D0%98%D0%B3%D0%BE%D1%80%D0%B5%D0%B2%D0%BD%D0%B0</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%A1%D0%BE%D1%8E%D0%B7+%D0%BF%D1%80%D0%BE%D1%84%D0%B5%D1%81%D1%81%D0%B8%D0%BE%D0%BD%D0%B0%D0%BB%D1%8C%D0%BD%D1%8B%D1%85+%D1%84%D0%B0%D1%80%D0%BC%D0%B0%D1%86%D0%B5%D0%B2%D1%82%D0%B8%D1%87%D0%B5%D1%81%D0%BA%D0%B8%D1%85+%D0%BE%D1%80%D0%B3%D0%B0%D0%BD%D0%B8%D0%B7%D0%B0%D1%86%D0%B8%D0%B9/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%A4%D0%90%D0%A1/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%A4%D0%97+%C2%AB%D0%9E%D0%B1+%D0%BE%D0%B1%D1%80%D0%B0%D1%89%D0%B5%D0%BD%D0%B8%D0%B8+%D0%BB%D0%B5%D0%BA%D0%B0%D1%80%D1%81%D1%82%D0%B2%D0%B5%D0%BD%D0%BD%D1%8B%D1%85+%D1%81%D1%80%D0%B5%D0%B4%D1%81%D1%82%D0%B2%C2%BB/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%A4%D0%B0%D1%80%D0%BC%D0%9C%D0%B5%D0%B4%D0%9E%D0%B1%D1%80%D0%B0%D1%89%D0%B5%D0%BD%D0%B8%D0%B5+2016/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%A4%D0%B0%D1%80%D0%BC%D0%B0-2020/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%AF%D0%B3%D1%83%D0%B4%D0%B8%D0%BD%D0%B0+%D0%A0%D0%BE%D0%B7%D0%B0/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%B0%D0%BD%D0%B0%D0%BB%D0%B8%D0%B7+%C2%AB%D0%B7%D0%B0%D1%82%D1%80%D0%B0%D1%82%D1%8B-%D1%8D%D1%84%D1%84%D0%B5%D0%BA%D1%82%D0%B8%D0%B2%D0%BD%D0%BE%D1%81%D1%82%D1%8C%C2%BB/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%B0%D0%BD%D0%B0%D0%BB%D0%B8%D0%B7+%D0%B7%D0%B0%D1%82%D1%80%D0%B0%D1%82%D1%8B-%D0%B2%D1%8B%D0%B3%D0%BE%D0%B4%D0%B0/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%B0%D0%BD%D0%B0%D0%BB%D0%B8%D0%B7+%D0%B7%D0%B0%D1%82%D1%80%D0%B0%D1%82%D1%8B-%D0%BF%D0%BE%D0%BB%D0%B5%D0%B7%D0%BD%D0%BE%D1%81%D1%82%D0%B8/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%B0%D0%BD%D0%B0%D0%BB%D0%B8%D0%B7+%D0%BC%D0%B8%D0%BD%D0%B8%D0%BC%D0%B8%D0%B7%D0%B0%D1%86%D0%B8%D0%B8+%D0%B7%D0%B0%D1%82%D1%80%D0%B0%D1%82/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%B0%D0%BD%D0%B0%D0%BB%D0%B8%D0%B7+%D0%BF%D0%BE%D0%B4%D0%B3%D1%80%D1%83%D0%BF%D0%BF/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%B0%D0%BD%D0%B0%D0%BB%D0%B8%D0%B7+%D0%BF%D0%BE%D0%BB%D0%B5%D0%B7%D0%BD%D0%BE%D1%81%D1%82%D0%B8+%D0%B7%D0%B0%D1%82%D1%80%D0%B0%D1%82/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%B0%D0%BD%D0%B0%D0%BB%D0%B8%D0%B7+%D0%BF%D0%BE%D1%82%D1%80%D0%B5%D0%B1%D0%BB%D0%B5%D0%BD%D0%B8%D1%8F/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%B0%D0%BD%D0%B0%D0%BB%D0%B8%D0%B7+%D1%80%D0%B5%D0%BD%D1%82%D0%B0%D0%B1%D0%B5%D0%BB%D1%8C%D0%BD%D0%BE%D1%81%D1%82%D0%B8/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%B0%D0%BD%D0%B0%D0%BB%D0%B8%D0%B7+%D1%81%D1%82%D0%BE%D0%B8%D0%BC%D0%BE%D1%81%D1%82%D0%B8+%D0%B1%D0%BE%D0%BB%D0%B5%D0%B7%D0%BD%D0%B8/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%B0%D0%BD%D0%B0%D0%BB%D0%B8%D0%B7+%D1%87%D1%83%D0%B2%D1%81%D1%82%D0%B2%D0%B8%D1%82%D0%B5%D0%BB%D1%8C%D0%BD%D0%BE%D1%81%D1%82%D0%B8/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%B0%D0%BD%D0%B0%D0%BB%D0%B8%D0%B7+%D1%8D%D1%84%D1%84%D0%B5%D0%BA%D1%82%D0%B8%D0%B2%D0%BD%D0%BE%D1%81%D1%82%D0%B8+%D0%B7%D0%B0%D1%82%D1%80%D0%B0%D1%82/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%B0%D0%BF%D1%82%D0%B5%D0%BA%D0%B0/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%B0%D0%BF%D1%82%D0%B5%D0%BA%D0%B8/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%B0%D0%BF%D1%82%D0%B5%D1%87%D0%BD%D1%8B%D0%B9+%D1%81%D0%B5%D0%B3%D0%BC%D0%B5%D0%BD%D1%82/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%B0%D1%81%D1%81%D0%B8%D1%81%D1%82%D0%B5%D0%BD%D1%82+%D0%BC%D0%B5%D0%BD%D0%B5%D0%B4%D0%B6%D0%B5%D1%80%D0%B0+%D0%BF%D0%BE+%D1%80%D0%B5%D0%B3%D0%B8%D1%81%D1%82%D1%80%D0%B0%D1%86%D0%B8%D0%B8/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%B0%D1%82%D0%B5%D1%80%D0%BE%D1%81%D0%BA%D0%BB%D0%B5%D1%80%D0%BE%D0%B7/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%B0%D1%82%D0%B5%D1%80%D0%BE%D1%82%D1%80%D0%BE%D0%BC%D0%B1%D0%BE%D0%B7/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%B1%D0%B5%D0%B7%D0%BE%D0%BF%D0%B0%D1%81%D0%BD%D0%BE%D1%81%D1%82%D1%8C+%D0%BC%D0%B5%D0%B4%D0%B8%D1%86%D0%B8%D0%BD%D1%81%D0%BA%D0%B8%D1%85+%D0%B8%D0%B7%D0%B4%D0%B5%D0%BB%D0%B8%D0%B9/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%B1%D0%B8%D0%BE%D0%B0%D0%BD%D0%B0%D0%BB%D0%BE%D0%B3/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%B1%D0%B8%D0%BE%D0%B4%D0%BE%D1%81%D1%82%D1%83%D0%BF%D0%BD%D0%BE%D1%81%D1%82%D1%8C/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%B1%D0%B8%D0%BE%D1%82%D1%80%D0%B0%D0%BD%D1%81%D1%84%D0%BE%D1%80%D0%BC%D0%B0%D1%86%D0%B8%D1%8F/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%B1%D0%B8%D0%BE%D1%8D%D0%BA%D0%B2%D0%B8%D0%B2%D0%B0%D0%BB%D0%B5%D0%BD%D1%82%D0%BD%D0%BE%D1%81%D1%82%D1%8C/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%B1%D0%BE%D0%BB%D1%8C%D0%BD%D0%B8%D1%86%D0%B0/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%B1%D0%BE%D0%BB%D1%8C%D0%BD%D0%B8%D1%87%D0%BD%D0%B0%D1%8F+%D0%B0%D0%BF%D1%82%D0%B5%D0%BA%D0%B0</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%B2%D0%B0%D0%BA%D0%B0%D0%BD%D1%81%D0%B8%D0%B8/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%B2%D0%B7%D0%B0%D0%B8%D0%BC%D0%BE%D0%B7%D0%B0%D0%BC%D0%B5%D0%BD%D1%8F%D0%B5%D0%BC%D0%BE%D1%81%D1%82%D1%8C+%D0%BB%D0%B5%D0%BA%D0%B0%D1%80%D1%81%D1%82%D0%B2/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%B2%D0%B7%D0%B0%D0%B8%D0%BC%D0%BE%D0%B7%D0%B0%D0%BC%D0%B5%D0%BD%D1%8F%D0%B5%D0%BC%D0%BE%D1%81%D1%82%D1%8C/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%B2%D0%BD%D0%B5%D1%81%D0%B5%D0%BD%D0%B8%D0%B5+%D0%B8%D0%B7%D0%BC%D0%B5%D0%BD%D0%B5%D0%BD%D0%B8%D0%B9+%D0%B2+%D1%80%D0%B5%D0%B3%D0%B8%D1%81%D1%82%D1%80%D0%B0%D1%86%D0%B8%D0%BE%D0%BD%D0%BD%D0%BE%D0%B5+%D0%B4%D0%BE%D1%81%D1%8C%D0%B5/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%B2%D0%BE%D0%B7%D0%BC%D0%B5%D1%89%D0%B5%D0%BD%D0%B8%D0%B5+%D0%B7%D0%B0%D1%82%D1%80%D0%B0%D1%82/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%B2%D1%8B%D1%81%D1%82%D0%B0%D0%B2%D0%BA%D0%B0/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%B3%D0%B8%D0%BF%D0%B5%D1%80%D1%85%D0%BE%D0%BB%D0%B5%D1%81%D1%82%D0%B5%D1%80%D0%B8%D0%BD%D0%B5%D0%BC%D0%B8%D1%8F/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%B3%D0%BE%D1%81%D0%B3%D0%B0%D1%80%D0%B0%D0%BD%D1%82%D0%B8%D0%B8/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%B3%D0%BE%D1%81%D0%BA%D0%BE%D0%BD%D1%82%D1%80%D0%B0%D0%BA%D1%82%D1%8B/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%B3%D0%BE%D1%81%D1%80%D0%B5%D0%B3%D0%B8%D1%81%D1%82%D1%80%D0%B0%D1%86%D0%B8%D1%8F/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%B3%D0%BE%D1%81%D1%83%D0%B4%D0%B0%D1%80%D1%81%D1%82%D0%B2%D0%B5%D0%BD%D0%BD%D0%B0%D1%8F+%D1%80%D0%B5%D0%B3%D0%B8%D1%81%D1%82%D1%80%D0%B0%D1%86%D0%B8%D1%8F+%D0%BB%D0%B5%D0%BA%D0%B0%D1%80%D1%81%D1%82%D0%B2%D0%B5%D0%BD%D0%BD%D1%8B%D1%85+%D1%81%D1%80%D0%B5%D0%B4%D1%81%D1%82%D0%B2+%D1%80%D0%B5%D1%84%D0%B5%D1%80%D0%B0%D1%82</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%B3%D0%BE%D1%81%D1%83%D0%B4%D0%B0%D1%80%D1%81%D1%82%D0%B2%D0%B5%D0%BD%D0%BD%D0%B0%D1%8F+%D1%80%D0%B5%D0%B3%D0%B8%D1%81%D1%82%D1%80%D0%B0%D1%86%D0%B8%D1%8F+%D0%BB%D0%B5%D0%BA%D0%B0%D1%80%D1%81%D1%82%D0%B2%D0%B5%D0%BD%D0%BD%D1%8B%D1%85+%D1%81%D1%80%D0%B5%D0%B4%D1%81%D1%82%D0%B2+%D1%80%D0%B5%D1%84%D0%B5%D1%80%D0%B0%D1%82/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%B4%D0%B6%D0%B5%D0%BD%D0%B5%D1%80%D0%B8%D0%BA%D0%B8/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%B4%D0%B8%D1%81%D0%BA%D0%BE%D0%BD%D1%82%D0%B8%D1%80%D0%BE%D0%B2%D0%B0%D0%BD%D0%B8%D0%B5/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%B4%D0%BE%D0%B1%D0%B0%D0%B2%D0%BB%D0%B5%D0%BD%D0%BD%D1%8B%D0%B5+%D0%B3%D0%BE%D0%B4%D1%8B+%D0%B6%D0%B8%D0%B7%D0%BD%D0%B8/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%B4%D0%BE%D0%BA%D0%BB%D0%B0%D0%B4/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%B4%D1%80%D0%B5%D0%B2%D0%BE+%D1%80%D0%B5%D1%88%D0%B5%D0%BD%D0%B8%D0%B9/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%B6%D1%83%D1%80%D0%BD%D0%B0%D0%BB</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%B6%D1%83%D1%80%D0%BD%D0%B0%D0%BB/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%B5%D0%BC%D0%BE%D1%81%D1%82%D1%8C/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%B7%D0%B0%D0%BA%D0%BE%D0%BD%D0%BE%D0%B4%D0%B0%D1%82%D0%B5%D0%BB%D1%8C%D1%81%D1%82%D0%B2%D0%BE</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%B7%D0%B0%D0%BA%D0%BE%D0%BD%D0%BE%D0%BF%D1%80%D0%BE%D0%B5%D0%BA%D1%82/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%B7%D0%B0%D0%BA%D0%BE%D0%BD%D0%BE%D0%BF%D1%80%D0%BE%D0%B5%D0%BA%D1%82/page/2/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%B7%D0%B0%D0%BA%D0%BE%D0%BD%D0%BE%D0%BF%D1%80%D0%BE%D0%B5%D0%BA%D1%82/page/3/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%B7%D0%B0%D0%BA%D0%BE%D0%BD%D0%BE%D0%BF%D1%80%D0%BE%D0%B5%D0%BA%D1%82/page/4/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%B7%D0%B0%D0%BA%D1%83%D0%BF%D0%BA%D0%B8+%D0%BB%D0%B5%D0%BA%D0%B0%D1%80%D1%81%D1%82%D0%B2/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%B7%D0%B0%D1%80%D0%BF%D0%BB%D0%B0%D1%82%D0%B0+%D0%BC%D0%B5%D0%BD%D0%B5%D0%B4%D0%B6%D0%B5%D1%80+%D0%BF%D0%BE+%D1%80%D0%B5%D0%B3%D0%B8%D1%81%D1%82%D1%80%D0%B0%D1%86%D0%B8%D0%B8+%D0%BB%D0%B5%D0%BA%D0%B0%D1%80%D1%81%D1%82%D0%B2%D0%B5%D0%BD%D0%BD%D1%8B%D1%85+%D1%81%D1%80%D0%B5%D0%B4%D1%81%D1%82%D0%B2/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%B7%D0%B0%D1%80%D1%83%D0%B1%D0%B5%D0%B6%D0%BD%D1%8B%D0%B5+%D0%B4%D0%B0%D0%BD%D0%BD%D1%8B%D0%B5/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%B7%D0%B0%D1%82%D1%80%D0%B0%D1%82%D1%8B-%D1%83%D1%82%D0%B8%D0%BB%D0%B8%D1%82%D0%B0%D1%80%D0%BD%D0%BE%D1%81%D1%82%D1%8C/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%B8%D0%B4%D0%B5%D0%BD%D1%82%D0%B8%D1%84%D0%B8%D0%BA%D0%B0%D1%86%D0%B8%D0%BE%D0%BD%D0%BD%D1%8B%D0%B9+%D0%BA%D0%BE%D0%B4+%D1%81%D1%83%D0%B1%D1%8A%D0%B5%D0%BA%D1%82%D0%B0+%D0%B8%D1%81%D1%81%D0%BB%D0%B5%D0%B4%D0%BE%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%B8%D0%B4%D0%B5%D0%BD%D1%82%D0%B8%D1%84%D0%B8%D0%BA%D0%B0%D1%86%D0%B8%D0%BE%D0%BD%D0%BD%D1%8B%D0%B9+%D1%81%D0%BF%D0%B8%D1%81%D0%BE%D0%BA+%D0%BF%D0%B0%D1%86%D0%B8%D0%B5%D0%BD%D1%82%D0%BE%D0%B2/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%B8%D0%B7%D0%B1%D1%8B%D1%82%D0%BE%D1%87%D0%BD%D0%B0%D1%8F+%D0%BC%D0%B0%D1%81%D1%81%D0%B0+%D1%82%D0%B5%D0%BB%D0%B0</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%B8%D0%B7%D0%B4%D0%B5%D0%BB%D0%B8%D1%8F+%D0%BC%D0%B5%D0%B4%D0%B8%D1%86%D0%B8%D0%BD%D1%81%D0%BA%D0%BE%D0%B3%D0%BE+%D0%BD%D0%B0%D0%B7%D0%BD%D0%B0%D1%87%D0%B5%D0%BD%D0%B8%D1%8F/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%B8%D0%BC%D0%BF%D0%BE%D1%80%D1%82%D0%BE%D0%B7%D0%B0%D0%BC%D0%B5%D1%89%D0%B5%D0%BD%D0%B8%D0%B5</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%B8%D0%BC%D0%BF%D0%BE%D1%80%D1%82%D0%BE%D0%B7%D0%B0%D0%BC%D0%B5%D1%89%D0%B5%D0%BD%D0%B8%D0%B5/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%B8%D0%BC%D0%BF%D0%BE%D1%80%D1%82+%D0%BB%D0%B5%D0%BA%D0%B0%D1%80%D1%81%D1%82%D0%B2/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%B8%D0%BC%D0%BF%D0%BE%D1%80%D1%82+%D0%BF%D1%80%D0%B5%D0%BF%D0%B0%D1%80%D0%B0%D1%82%D0%BE%D0%B2/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%B8%D0%BC%D0%BF%D0%BE%D1%80%D1%82/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%B8%D0%BD%D1%82%D0%B5%D0%BB%D0%BB%D0%B5%D0%BA%D1%82%D1%83%D0%B0%D0%BB%D1%8C%D0%BD%D0%B0%D1%8F+%D1%81%D0%BE%D0%B1%D1%81%D1%82%D0%B2%D0%B5%D0%BD%D0%BD%D0%BE%D1%81%D1%82%D1%8C/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%B8%D1%81%D1%81%D0%BB%D0%B5%D0%B4%D1%83%D0%B5%D0%BC%D0%B0%D1%8F+%D0%BF%D0%BE%D0%BF%D1%83%D0%BB%D1%8F%D1%86%D0%B8%D1%8F/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%B8%D1%81%D1%82%D0%BE%D1%87%D0%BD%D0%B8%D0%BA%D0%B8+%D1%84%D0%B8%D0%BD%D0%B0%D0%BD%D1%81%D0%B8%D1%80%D0%BE%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%BA%D0%B0%D0%BD%D0%B0%D0%BB%D1%8B+%D1%81%D0%B1%D1%8B%D1%82%D0%B0/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%BA%D0%B0%D1%87%D0%B5%D1%81%D1%82%D0%B2%D0%BE+%D0%B6%D0%B8%D0%B7%D0%BD%D0%B8/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%BA%D0%BB%D0%B8%D0%BD%D0%B8%D0%BA%D0%BE-%D1%81%D1%82%D0%B0%D1%82%D0%B8%D1%81%D1%82%D0%B8%D1%87%D0%B5%D1%81%D0%BA%D0%B8%D0%B5+%D0%B3%D1%80%D1%83%D0%BF%D0%BF%D1%8B/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%BA%D0%BB%D0%B8%D0%BD%D0%B8%D0%BA%D0%BE-%D1%8D%D0%BA%D0%BE%D0%BD%D0%BE%D0%BC%D0%B8%D1%87%D0%B5%D1%81%D0%BA%D0%B8%D0%B5+%D0%B8%D1%81%D1%81%D0%BB%D0%B5%D0%B4%D0%BE%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%BA%D0%BB%D0%B8%D0%BD%D0%B8%D0%BA%D0%BE-%D1%8D%D0%BA%D0%BE%D0%BD%D0%BE%D0%BC%D0%B8%D1%87%D0%B5%D1%81%D0%BA%D0%B8%D0%B9+%D0%B0%D0%BD%D0%B0%D0%BB%D0%B8%D0%B7/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%BA%D0%BB%D0%B8%D0%BD%D0%B8%D1%87%D0%B5%D1%81%D0%BA%D0%B0%D1%8F+%D1%84%D0%B0%D1%80%D0%BC%D0%B0%D0%BA%D0%BE%D0%BB%D0%BE%D0%B3%D0%B8%D1%8F/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%BA%D0%BB%D0%B8%D0%BD%D0%B8%D1%87%D0%B5%D1%81%D0%BA%D0%B0%D1%8F+%D1%84%D0%B0%D1%80%D0%BC%D0%B0%D1%86%D0%B8%D1%8F/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%BA%D0%BB%D0%B8%D0%BD%D0%B8%D1%87%D0%B5%D1%81%D0%BA%D0%B8%D0%B5+%D0%B8%D1%81%D1%81%D0%BB%D0%B5%D0%B4%D0%BE%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%BA%D0%BE%D0%B3%D0%BE%D1%80%D1%82%D0%BD%D0%BE%D0%B5+%D0%B8%D1%81%D1%81%D0%BB%D0%B5%D0%B4%D0%BE%D0%B2%D0%B0%D0%BD%D0%B8%D0%B5/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%BA%D0%BE%D0%BD%D0%B3%D1%80%D0%B5%D1%81%D1%81/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%BA%D0%BE%D0%BD%D1%82%D1%80%D0%B0%D0%BA%D1%82%D0%BD%D0%B0%D1%8F+%D1%81%D0%B8%D1%81%D1%82%D0%B5%D0%BC%D0%B0/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%BA%D0%BE%D0%BD%D1%82%D1%80%D0%B0%D0%BA%D1%82%D0%BD%D0%BE-%D0%B8%D1%81%D1%81%D0%BB%D0%B5%D0%B4%D0%BE%D0%B2%D0%B0%D1%82%D0%B5%D0%BB%D1%8C%D1%81%D0%BA%D0%B0%D1%8F+%D0%BE%D1%80%D0%B3%D0%B0%D0%BD%D0%B8%D0%B7%D0%B0%D1%86%D0%B8%D1%8F/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%BA%D0%BE%D0%BD%D1%82%D1%80%D0%B0%D0%BA%D1%82%D0%BD%D1%8B%D0%B5+%D0%B8%D1%81%D1%81%D0%BB%D0%B5%D0%B4%D0%BE%D0%B2%D0%B0%D1%82%D0%B5%D0%BB%D1%8C%D1%81%D0%BA%D0%B8%D0%B5+%D0%BE%D1%80%D0%B3%D0%B0%D0%BD%D0%B8%D0%B7%D0%B0%D1%86%D0%B8%D0%B8/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%BA%D0%BE%D0%BD%D1%82%D1%80%D0%B0%D0%BA%D1%82+%D0%BD%D0%B0+%D0%BF%D0%BE%D1%81%D1%82%D0%B0%D0%B2%D0%BA%D1%83+%D0%BB%D0%B5%D0%BA%D0%B0%D1%80%D1%81%D1%82%D0%B2/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%BA%D0%BE%D0%BD%D1%82%D1%80%D0%BE%D0%BB%D1%8C+%D0%BA%D0%B0%D1%87%D0%B5%D1%81%D1%82%D0%B2%D0%B0+%D0%BB%D0%B5%D0%BA%D0%B0%D1%80%D1%81%D1%82%D0%B2%D0%B5%D0%BD%D0%BD%D1%8B%D1%85+%D1%81%D1%80%D0%B5%D0%B4%D1%81%D1%82%D0%B2/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%BA%D0%BE%D1%81%D0%B2%D0%B5%D0%BD%D0%BD%D1%8B%D0%B5+%D0%B7%D0%B0%D1%82%D1%80%D0%B0%D1%82%D1%8B/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%BA%D1%80%D0%B8%D1%82%D0%B5%D1%80%D0%B8%D0%B8+%D0%B8%D1%81%D0%BA%D0%BB%D1%8E%D1%87%D0%B5%D0%BD%D0%B8%D1%8F</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%BA%D1%80%D0%B8%D1%82%D0%B5%D1%80%D0%B8%D0%B8+%D0%B8%D1%81%D0%BA%D0%BB%D1%8E%D1%87%D0%B5%D0%BD%D0%B8%D1%8F/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%BB%D0%B5%D0%BA%D0%B0%D1%80%D1%81%D1%82%D0%B2%D0%B5%D0%BD%D0%BD%D0%BE%D0%B5+%D0%BE%D0%B1%D0%B5%D1%81%D0%BF%D0%B5%D1%87%D0%B5%D0%BD%D0%B8%D0%B5/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%BB%D0%B5%D0%BA%D0%B0%D1%80%D1%81%D1%82%D0%B2%D0%B5%D0%BD%D0%BD%D1%8B%D0%B5+%D1%81%D1%80%D0%B5%D0%B4%D1%81%D1%82%D0%B2%D0%B0/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%BB%D0%B5%D0%BA%D0%BE%D0%B1%D0%B5%D1%81%D0%BF%D0%B5%D1%87%D0%B5%D0%BD%D0%B8%D0%B5/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%BB%D0%B8%D1%86%D0%B5%D0%BD%D0%B7%D0%B8%D1%80%D0%BE%D0%B2%D0%B0%D0%BD%D0%B8%D0%B5/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%BB%D1%8C%D0%B3%D0%BE%D1%82%D0%BD%D0%B8%D0%BA%D0%B8/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%BB%D1%8C%D0%B3%D0%BE%D1%82%D0%BD%D0%BE%D0%B5+%D0%BB%D0%B5%D0%BA%D0%BE%D0%B1%D0%B5%D1%81%D0%BF%D0%B5%D1%87%D0%B5%D0%BD%D0%B8%D0%B5/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%BC%D0%B5%D0%B4%D0%B8%D0%BA%D0%BE-%D1%8D%D0%BA%D0%BE%D0%BD%D0%BE%D0%BC%D0%B8%D1%87%D0%B5%D1%81%D0%BA%D0%B8%D0%B9+%D1%81%D1%82%D0%B0%D0%BD%D0%B4%D0%B0%D1%80%D1%82</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%BC%D0%B5%D0%B4%D0%B8%D0%BA%D0%BE-%D1%8D%D0%BA%D0%BE%D0%BD%D0%BE%D0%BC%D0%B8%D1%87%D0%B5%D1%81%D0%BA%D0%B8%D0%B9+%D1%81%D1%82%D0%B0%D0%BD%D0%B4%D0%B0%D1%80%D1%82/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%BC%D0%B5%D0%B4%D0%B8%D1%86%D0%B8%D0%BD%D1%81%D0%BA%D0%B0%D1%8F+%D0%BF%D1%80%D0%BE%D0%BC%D1%8B%D1%88%D0%BB%D0%B5%D0%BD%D0%BD%D0%BE%D1%81%D1%82%D1%8C/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%BC%D0%B5%D0%B4%D0%B8%D1%86%D0%B8%D0%BD%D1%81%D0%BA%D0%B8%D0%B5+%D0%BE%D1%80%D0%B3%D0%B0%D0%BD%D0%B8%D0%B7%D0%B0%D1%86%D0%B8%D0%B8/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%BC%D0%B5%D0%B4%D0%B8%D1%86%D0%B8%D0%BD%D1%81%D0%BA%D0%B8%D0%B5+%D1%83%D1%81%D0%BB%D1%83%D0%B3%D0%B8/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%BC%D0%BE%D0%B4%D0%B5%D0%BB%D0%B8%D1%80%D0%BE%D0%B2%D0%B0%D0%BD%D0%B8%D0%B5/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%BC%D0%BE%D0%B4%D0%B5%D0%BB%D1%8C+%D0%9C%D0%B0%D1%80%D0%BA%D0%BE%D0%B2%D0%B0/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%BC%D0%BE%D0%BD%D0%B8%D1%82%D0%BE%D1%80%D0%B8%D0%BD%D0%B3/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%BD%D0%B0%D0%B4%D0%B1%D0%B0%D0%B2%D0%BA%D0%B8+%D0%BA+%D1%86%D0%B5%D0%BD%D0%B0%D0%BC/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%BD%D0%B0%D0%B4%D0%BB%D0%B5%D0%B6%D0%B0%D1%89%D0%B0%D1%8F+%D1%8D%D0%BF%D0%B8%D0%B4%D0%B5%D0%BC%D0%B8%D0%BE%D0%BB%D0%BE%D0%B3%D0%B8%D1%87%D0%B5%D1%81%D0%BA%D0%B0%D1%8F+%D0%BF%D1%80%D0%B0%D0%BA%D1%82%D0%B8%D0%BA%D0%B0</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%BD%D0%B0%D1%83%D1%87%D0%BD%D1%8B%D0%B9+%D0%BE%D1%82%D1%87%D0%B5%D1%82</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%BD%D0%B5%D0%BF%D1%80%D1%8F%D0%BC%D1%8B%D0%B5+%D0%B7%D0%B0%D1%82%D1%80%D0%B0%D1%82%D1%8B/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%BD%D0%BE%D0%BC%D0%B5%D0%BD%D0%BA%D0%BB%D0%B0%D1%82%D1%83%D1%80%D0%B0/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%BD%D0%BE%D1%80%D0%BC%D0%B0%D1%82%D0%B8%D0%B2%D0%BD%D0%BE-%D0%BF%D1%80%D0%B0%D0%B2%D0%BE%D0%B2%D0%BE%D0%B5+%D1%80%D0%B5%D0%B3%D1%83%D0%BB%D0%B8%D1%80%D0%BE%D0%B2%D0%B0%D0%BD%D0%B8%D0%B5/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%BE%D0%B1%D1%80%D0%B0%D1%89%D0%B5%D0%BD%D0%B8%D0%B5+%D0%BB%D0%B5%D0%BA%D0%B0%D1%80%D1%81%D1%82%D0%B2%D0%B5%D0%BD%D0%BD%D1%8B%D1%85+%D1%81%D1%80%D0%B5%D0%B4%D1%81%D1%82%D0%B2/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%BE%D0%B1%D1%80%D0%B0%D1%89%D0%B5%D0%BD%D0%B8%D0%B5+%D0%BB%D0%B5%D0%BA%D0%B0%D1%80%D1%81%D1%82%D0%B2/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%BE%D0%B1%D1%8A%D0%B5%D0%BC+%D0%B8%D0%BC%D0%BF%D0%BE%D1%80%D1%82%D0%B0/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%BE%D0%B4%D0%BD%D0%BE%D0%BC%D0%BE%D0%BC%D0%B5%D0%BD%D1%82%D0%BD%D0%BE%D0%B5+%D0%B8%D1%81%D1%81%D0%BB%D0%B5%D0%B4%D0%BE%D0%B2%D0%B0%D0%BD%D0%B8%D0%B5/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%BE%D0%BA%D0%B0%D0%B7%D0%B0%D0%BD%D0%B8%D0%B5+%D0%BC%D0%B5%D0%B4%D0%B8%D1%86%D0%B8%D0%BD%D1%81%D0%BA%D0%BE%D0%B9+%D0%BF%D0%BE%D0%BC%D0%BE%D1%89%D0%B8/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%BE%D0%BD%D0%BB%D0%B0%D0%B9%D0%BD+%D0%BE%D0%B1%D1%83%D1%87%D0%B5%D0%BD%D0%B8%D0%B5/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%BE%D0%BF%D0%B8%D1%81%D0%B0%D0%BD%D0%B8%D0%B5+%D1%81%D0%B5%D1%80%D0%B8%D0%B8+%D1%81%D0%BB%D1%83%D1%87%D0%B0%D0%B5%D0%B2/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%BE%D0%BF%D0%B8%D1%81%D0%B0%D0%BD%D0%B8%D0%B5+%D1%81%D0%BB%D1%83%D1%87%D0%B0%D0%B5%D0%B2/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%BE%D1%80%D0%B3%D0%B0%D0%BD%D0%B8%D0%B7%D0%B0%D1%86%D0%B8%D1%8F+%D0%BE%D1%86%D0%B5%D0%BD%D0%BA%D0%B8/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%BE%D1%80%D1%84%D0%B0%D0%BD%D0%BD%D1%8B%D0%B5+%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%BE%D1%80%D1%84%D0%B0%D0%BD%D0%BD%D1%8B%D0%B5+%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F/page/2/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%BE%D1%80%D1%84%D0%B0%D0%BD%D0%BD%D1%8B%D0%B5+%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F/page/3/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%BE%D1%82%D1%87%D0%B5%D1%82/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%BE%D1%86%D0%B5%D0%BD%D0%BA%D0%B0+%D0%B7%D0%B0%D1%82%D1%80%D0%B0%D1%82/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%BE%D1%86%D0%B5%D0%BD%D0%BA%D0%B0+%D0%B8%D1%81%D1%85%D0%BE%D0%B4%D0%BE%D0%B2/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%BE%D1%86%D0%B5%D0%BD%D0%BA%D0%B0+%D0%BC%D0%B5%D0%B4%D0%B8%D1%86%D0%B8%D0%BD%D1%81%D0%BA%D0%B8%D1%85+%D1%82%D0%B5%D1%85%D0%BD%D0%BE%D0%BB%D0%BE%D0%B3%D0%B8%D0%B9/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%BE%D1%86%D0%B5%D0%BD%D0%BA%D0%B0+%D0%BC%D0%B5%D0%B4%D0%B8%D1%86%D0%B8%D0%BD%D1%81%D0%BA%D0%B8%D1%85+%D1%82%D0%B5%D1%85%D0%BD%D0%BE%D0%BB%D0%BE%D0%B3%D0%B8%D0%B9/page/3/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%BE%D1%86%D0%B5%D0%BD%D0%BA%D0%B0+%D0%BC%D0%B5%D0%B4%D0%B8%D1%86%D0%B8%D0%BD%D1%81%D0%BA%D0%BE%D0%B9+%D1%82%D0%B5%D1%85%D0%BD%D0%BE%D0%BB%D0%BE%D0%B3%D0%B8%D0%B8/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%BF%D0%B0%D0%B4%D0%B5%D0%BD%D0%B8%D0%B5+%D0%BA%D1%83%D1%80%D1%81%D0%B0+%D1%80%D1%83%D0%B1%D0%BB%D1%8F/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%BF%D0%B0%D1%82%D0%B5%D0%BD%D1%82+%D0%BD%D0%B0+%D0%BB%D0%B5%D0%BA%D0%B0%D1%80%D1%81%D1%82%D0%B2%D0%B0/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%BF%D0%B5%D1%80%D0%B5%D0%BA%D1%80%D0%B5%D1%81%D1%82%D0%BD%D0%BE%D0%B5+%D0%B8%D1%81%D1%81%D0%BB%D0%B5%D0%B4%D0%BE%D0%B2%D0%B0%D0%BD%D0%B8%D0%B5/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%BF%D0%B5%D1%80%D0%B5%D1%87%D0%B5%D0%BD%D1%8C+%D0%96%D0%9D%D0%92%D0%9B%D0%9F/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%BF%D0%B5%D1%80%D0%B5%D1%87%D0%B5%D0%BD%D1%8C/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%BF%D0%B5%D1%80%D1%81%D0%BF%D0%B5%D0%BA%D1%82%D0%B8%D0%B2%D1%8B+%D0%BF%D1%80%D0%B8%D0%BC%D0%B5%D0%BD%D0%B5%D0%BD%D0%B8%D1%8F/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%BF%D0%B5%D1%80%D1%81%D0%BF%D0%B5%D0%BA%D1%82%D0%B8%D0%B2%D1%8B/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%BF%D0%B8%D0%BB%D0%BE%D1%82%D0%BD%D0%BE%D0%B5+%D0%B8%D1%81%D1%81%D0%BB%D0%B5%D0%B4%D0%BE%D0%B2%D0%B0%D0%BD%D0%B8%D0%B5/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%BF%D0%BB%D0%B0%D1%86%D0%B5%D0%B1%D0%BE-%D0%BA%D0%BE%D0%BD%D1%82%D1%80%D0%BE%D0%BB%D0%B8%D1%80%D1%83%D0%B5%D0%BC%D0%BE%D0%B5+%D0%B8%D1%81%D1%81%D0%BB%D0%B5%D0%B4%D0%BE%D0%B2%D0%B0%D0%BD%D0%B8%D0%B5/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%BF%D0%BE%D1%80%D1%8F%D0%B4%D0%BE%D0%BA+%D0%BE%D1%86%D0%B5%D0%BD%D0%BA%D0%B8/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%BF%D0%BE%D1%82%D1%80%D0%B5%D0%B1%D0%BB%D0%B5%D0%BD%D0%B8%D0%B5/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%BF%D0%BE%D1%82%D1%80%D0%B5%D0%B1%D0%BD%D0%BE%D1%81%D1%82%D1%8C/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%BF%D1%80%D0%B5%D0%B4%D0%B5%D0%BB%D1%8C%D0%BD%D1%8B%D0%B5+%D0%BE%D1%82%D0%BF%D1%83%D1%81%D0%BA%D0%BD%D1%8B%D0%B5+%D1%86%D0%B5%D0%BD%D1%8B/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%BF%D1%80%D0%B5%D0%B7%D0%B5%D0%BD%D1%82%D0%B0%D1%86%D0%B8%D1%8F/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%BF%D1%80%D0%B5%D0%BC%D0%B8%D1%8F/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%BF%D1%80%D0%BE%D0%B3%D1%80%D0%B0%D0%BC%D0%BC%D0%BD%D0%BE%D0%B5+%D0%BE%D0%B1%D0%B5%D1%81%D0%BF%D0%B5%D1%87%D0%B5%D0%BD%D0%B8%D0%B5/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%BF%D1%80%D0%BE%D0%B8%D0%B7%D0%B2%D0%BE%D0%B4%D1%81%D1%82%D0%B2%D0%BE+%D0%BB%D0%B5%D0%BA%D0%B0%D1%80%D1%81%D1%82%D0%B2/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%BF%D1%80%D0%BE%D0%B8%D0%B7%D0%B2%D0%BE%D0%B4%D1%81%D1%82%D0%B2%D0%BE/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%BF%D1%80%D0%BE%D1%81%D1%82%D1%8B%D0%B5+%D0%BC%D0%B5%D0%B4%D0%B8%D1%86%D0%B8%D0%BD%D1%81%D0%BA%D0%B8%D0%B5+%D1%83%D1%81%D0%BB%D1%83%D0%B3%D0%B8/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D0%BF%D1%80%D1%8F%D0%BC%D1%8B%D0%B5+%D0%B7%D0%B0%D1%82%D1%80%D0%B0%D1%82%D1%8B/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D1%80%D0%B5%D0%B0%D0%BB%D0%B8%D0%B7%D0%B0%D1%86%D0%B8%D1%8F+%D0%BB%D0%B5%D0%BA%D0%B0%D1%80%D1%81%D1%82%D0%B2/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D1%80%D0%B5%D0%B3%D0%B8%D1%81%D1%82%D1%80%D0%B0%D1%86%D0%B8%D1%8F/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D1%80%D0%B5%D0%B8%D0%BC%D0%B1%D0%B5%D1%80%D1%81%D0%BC%D0%B5%D0%BD%D1%82/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D1%80%D0%B5%D0%B8%D0%BC%D0%B1%D1%83%D1%80%D1%81%D0%B0%D1%86%D0%B8%D1%8F/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D1%80%D0%B5%D1%82%D1%80%D0%BE%D1%81%D0%BF%D0%B5%D0%BA%D1%82%D0%B8%D0%B2%D0%BD%D0%BE%D0%B5+%D0%B8%D1%81%D1%81%D0%BB%D0%B5%D0%B4%D0%BE%D0%B2%D0%B0%D0%BD%D0%B8%D0%B5/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D1%80%D0%BE%D0%B6%D0%B4%D0%B0%D0%B5%D0%BC%D0%BE%D1%81%D1%82%D1%8C/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D1%80%D0%BE%D1%81%D1%81%D0%B8%D0%B9%D1%81%D0%BA%D0%B8%D0%B5+%D1%84%D0%B0%D1%80%D0%BC%D0%BA%D0%BE%D0%BC%D0%BF%D0%B0%D0%BD%D0%B8%D0%B8/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D1%80%D0%BE%D1%81%D1%82/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D1%80%D1%8B%D0%BD%D0%BE%D0%BA+%D0%A3%D0%97-%D0%BE%D0%B1%D0%BE%D1%80%D1%83%D0%B4%D0%BE%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D1%80%D1%8B%D0%BD%D0%BE%D0%BA/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D1%81%D0%B5%D1%80%D0%B2%D0%B8%D1%81%D1%8B/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D1%81%D0%B8%D0%BC%D1%83%D0%BB%D1%8F%D1%86%D0%B8%D0%B8+%D0%9C%D0%BE%D0%BD%D1%82%D0%B5-%D0%9A%D0%B0%D1%80%D0%BB%D0%BE/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D1%81%D0%BB%D0%B0%D0%B9%D0%B4/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D1%81%D0%BC%D0%B5%D1%80%D1%82%D0%BD%D0%BE%D1%81%D1%82%D1%8C/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D1%81%D0%BE%D0%B7%D0%B4%D0%B0%D0%BD%D0%B8%D0%B5+%D0%BF%D1%80%D0%B5%D0%B7%D0%B5%D0%BD%D1%82%D0%B0%D1%86%D0%B8%D0%B8/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D1%81%D1%80%D0%B0%D0%B2%D0%BD%D0%B8%D1%82%D0%B5%D0%BB%D1%8C%D0%BD%D0%BE%D0%B5+%D0%B8%D1%81%D1%81%D0%BB%D0%B5%D0%B4%D0%BE%D0%B2%D0%B0%D0%BD%D0%B8%D0%B5/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D1%81%D1%82%D0%B0%D0%B2%D0%BA%D0%B0/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D1%81%D1%82%D0%B0%D0%BD%D0%B4%D0%B0%D1%80%D1%82+%D0%BC%D0%B5%D0%B4%D0%B8%D1%86%D0%B8%D0%BD%D1%81%D0%BA%D0%BE%D0%B9+%D0%BF%D0%BE%D0%BC%D0%BE%D1%89%D0%B8/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D1%81%D1%82%D0%B0%D1%82%D0%B8%D0%BD%D1%8B/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D1%81%D1%82%D0%B0%D1%82%D0%B8%D1%81%D1%82%D0%B8%D0%BA%D0%B0/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D1%81%D1%82%D0%B0%D1%86%D0%B8%D0%BE%D0%BD%D0%B0%D1%80%D0%BD%D1%8B%D0%B9+%D1%84%D0%BE%D1%80%D0%BC%D1%83%D0%BB%D1%8F%D1%80/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D1%81%D1%82%D0%BE%D0%B8%D0%BC%D0%BE%D1%81%D1%82%D1%8C+%D0%BB%D0%B5%D0%BA%D0%B0%D1%80%D1%81%D1%82%D0%B2</loc></url><url><loc>https://market-access-solutions.ru/tags/%D1%81%D1%83%D0%B1%D0%B2%D0%B5%D0%BD%D1%86%D0%B8%D0%B8+%D1%80%D0%B5%D0%B3%D0%B8%D0%BE%D0%BD%D0%B0%D0%BC/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D1%81td/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D1%83%D1%81%D0%BB%D0%BE%D0%B2%D0%BD%D1%8B%D0%B5+%D0%B5%D0%B4%D0%B8%D0%BD%D0%B8%D1%86%D1%8B+%D1%82%D1%80%D1%83%D0%B4%D0%BE%D0%B7%D0%B0%D1%82%D1%80%D0%B0%D1%82/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D1%84%D0%B0%D1%80%D0%BC%D0%B0%D0%BA%D0%BE%D0%B3%D0%B5%D0%BD%D0%B5%D1%82%D0%B8%D0%BA%D0%B0</loc></url><url><loc>https://market-access-solutions.ru/tags/%D1%84%D0%B0%D1%80%D0%BC%D0%B0%D0%BA%D0%BE%D0%B3%D0%B5%D0%BD%D0%B5%D1%82%D0%B8%D0%BA%D0%B0/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D1%84%D0%B0%D1%80%D0%BC%D0%B0%D0%BA%D0%BE%D0%B4%D0%B8%D0%BD%D0%B0%D0%BC%D0%B8%D0%BA%D0%B0/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D1%84%D0%B0%D1%80%D0%BC%D0%B0%D0%BA%D0%BE%D0%BA%D0%B8%D0%BD%D0%B5%D1%82%D0%B8%D0%BA%D0%B0</loc></url><url><loc>https://market-access-solutions.ru/tags/%D1%84%D0%B0%D1%80%D0%BC%D0%B0%D0%BA%D0%BE%D0%BA%D0%B8%D0%BD%D0%B5%D1%82%D0%B8%D0%BA%D0%B0/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D1%84%D0%B0%D1%80%D0%BC%D0%B0%D0%BA%D0%BE%D1%82%D0%B5%D1%80%D0%B0%D0%BF%D0%B8%D1%8F/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D1%84%D0%B0%D1%80%D0%BC%D0%B0%D0%BA%D0%BE%D1%8D%D0%BA%D0%BE%D0%BD%D0%BE%D0%BC%D0%B8%D0%BA%D0%B0/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D1%84%D0%B0%D1%80%D0%BC%D0%B0%D0%BA%D0%BE%D1%8D%D0%BA%D0%BE%D0%BD%D0%BE%D0%BC%D0%B8%D1%87%D0%B5%D1%81%D0%BA%D0%B8%D0%B5+%D0%B8%D1%81%D1%81%D0%BB%D0%B5%D0%B4%D0%BE%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D1%84%D0%B0%D1%80%D0%BC%D0%B0%D0%BA%D0%BE%D1%8D%D0%BF%D0%B8%D0%B4%D0%B5%D0%BC%D0%B8%D0%BE%D0%BB%D0%BE%D0%B3%D0%B8%D1%8F/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D1%84%D0%B0%D1%80%D0%BC%D0%B0%D1%86%D0%B5%D0%B2%D1%82%D0%B8%D1%87%D0%B5%D1%81%D0%BA%D0%B0%D1%8F+%D0%B4%D0%B5%D1%8F%D1%82%D0%B5%D0%BB%D1%8C%D0%BD%D0%BE%D1%81%D1%82%D1%8C/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D1%84%D0%B0%D1%80%D0%BC%D0%BF%D1%80%D0%BE%D0%BC%D1%8B%D1%88%D0%BB%D0%B5%D0%BD%D0%BD%D0%BE%D1%81%D1%82%D1%8C/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D1%84%D0%B0%D1%80%D0%BC%D1%80%D1%8B%D0%BD%D0%BE%D0%BA</loc></url><url><loc>https://market-access-solutions.ru/tags/%D1%84%D0%B0%D1%80%D0%BC%D1%80%D1%8B%D0%BD%D0%BE%D0%BA/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D1%84%D0%B8%D0%BD%D0%B0%D0%BD%D1%81%D0%B8%D1%80%D0%BE%D0%B2%D0%B0%D0%BD%D0%B8%D0%B5/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D1%84%D0%BE%D1%80%D0%BC%D0%B0%D1%82+%D1%80%D0%B5%D0%B3%D0%B8%D1%81%D1%82%D1%80%D0%B0%D1%86%D0%B8%D0%BE%D0%BD%D0%BD%D0%BE%D0%B3%D0%BE+%D0%B4%D0%BE%D1%81%D1%8C%D0%B5/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D1%86%D0%B5%D0%BD%D0%BE%D0%BE%D0%B1%D1%80%D0%B0%D0%B7%D0%BE%D0%B2%D0%B0%D0%BD%D0%B8%D0%B5/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D1%86%D0%B5%D0%BD%D1%8B+%D0%BD%D0%B0+%D0%BA%D0%BB%D0%B5%D0%BA%D0%B0%D1%80%D1%81%D1%82%D0%B2%D0%B0/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D1%86%D0%B5%D0%BD%D1%8B+%D0%BD%D0%B0+%D0%BB%D0%B5%D0%BA%D0%B0%D1%80%D1%81%D1%82%D0%B2%D0%B0/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D1%8D%D0%BA%D1%81%D0%BF%D0%B5%D1%80%D1%82%D0%B8%D0%B7%D0%B0+%D0%BA%D0%B0%D1%87%D0%B5%D1%81%D1%82%D0%B2%D0%B0/</loc></url><url><loc>https://market-access-solutions.ru/tags/%D1%8D%D0%BF%D0%B8%D0%B4%D0%B5%D0%BC%D0%B8%D0%BE%D0%BB%D0%BE%D0%B3%D0%B8%D1%8F/</loc></url><url><loc>https://market-access-solutions.ru/tags/2010/</loc></url><url><loc>https://market-access-solutions.ru/tags/2011/</loc></url><url><loc>https://market-access-solutions.ru/tags/2013/</loc></url><url><loc>https://market-access-solutions.ru/tags/7+%D0%BD%D0%BE%D0%B7%D0%BE%D0%BB%D0%BE%D0%B3%D0%B8%D0%B9/</loc></url><url><loc>https://market-access-solutions.ru/tags/ABC-%D0%B0%D0%BD%D0%B0%D0%BB%D0%B8%D0%B7/</loc></url><url><loc>https://market-access-solutions.ru/tags/ARS+PharmRussia/</loc></url><url><loc>https://market-access-solutions.ru/tags/BIA/</loc></url><url><loc>https://market-access-solutions.ru/tags/CEA/</loc></url><url><loc>https://market-access-solutions.ru/tags/COI/</loc></url><url><loc>https://market-access-solutions.ru/tags/CRO/</loc></url><url><loc>https://market-access-solutions.ru/tags/CUA/</loc></url><url><loc>https://market-access-solutions.ru/tags/Clinical+Trial+Management+Systems/</loc></url><url><loc>https://market-access-solutions.ru/tags/Contract+Research+Organization/</loc></url><url><loc>https://market-access-solutions.ru/tags/Cost-of-illness/</loc></url><url><loc>https://market-access-solutions.ru/tags/Cross-over+Study/</loc></url><url><loc>https://market-access-solutions.ru/tags/DSM+Group/</loc></url><url><loc>https://market-access-solutions.ru/tags/EQ-5D/</loc></url><url><loc>https://market-access-solutions.ru/tags/Exclusion+Criteria/</loc></url><url><loc>https://market-access-solutions.ru/tags/Flex+Databases/</loc></url><url><loc>https://market-access-solutions.ru/tags/GMP/</loc></url><url><loc>https://market-access-solutions.ru/tags/HRQoL/</loc></url><url><loc>https://market-access-solutions.ru/tags/HTA/</loc></url><url><loc>https://market-access-solutions.ru/tags/HUI/</loc></url><url><loc>https://market-access-solutions.ru/tags/Health+Technology+Assessment/</loc></url><url><loc>https://market-access-solutions.ru/tags/ICER/</loc></url><url><loc>https://market-access-solutions.ru/tags/Identification+List/</loc></url><url><loc>https://market-access-solutions.ru/tags/LYG/</loc></url><url><loc>https://market-access-solutions.ru/tags/Pilot+Study/</loc></url><url><loc>https://market-access-solutions.ru/tags/Placebo-Controlled+Trial/</loc></url><url><loc>https://market-access-solutions.ru/tags/Protocol+Violation</loc></url><url><loc>https://market-access-solutions.ru/tags/QALY/</loc></url><url><loc>https://market-access-solutions.ru/tags/RNC+Pharma/</loc></url><url><loc>https://market-access-solutions.ru/tags/Retrospective+Study/</loc></url><url><loc>https://market-access-solutions.ru/tags/SmartPharma%C2%AE+Awards/</loc></url><url><loc>https://market-access-solutions.ru/tags/Subject+Identification+Code/</loc></url><url><loc>https://market-access-solutions.ru/tags/VEN-%D0%B0%D0%BD%D0%B0%D0%BB%D0%B8%D0%B7/</loc></url><url><loc>https://market-access-solutions.ru/tags/cost+minimization+analysis/</loc></url><url><loc>https://market-access-solutions.ru/tags/cost-benefit+analysis/</loc></url><url><loc>https://market-access-solutions.ru/tags/cost-effectiveness+analysis/</loc></url><url><loc>https://market-access-solutions.ru/tags/cost-utility+analysis/</loc></url><url><loc>https://market-access-solutions.ru/tags/in-bulk/</loc></url><url><loc>https://market-access-solutions.ru/tags/pharmsuite/</loc></url><url><loc>https://market-access-solutions.ru/vacancy.html</loc></url><url><loc>https://market-access-solutions.ru/vacancy_eng.html</loc></url><url><loc>https://market-access-solutions.ru/vacansii</loc></url></urlset>